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Abbreviation Ful name 
AF-1 Activator function 1 
AOP Adverse outcome pathway 
AR Androgen receptor 
BFR Brominated flame retardant 
CEC Contaminants of emerging concern 
DBD DNA-binding domain 
DMEM Dulbecco’s modified eagle’s medium 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
EC50 Half maximal effect concentration 
EDC Endocrine disrupting compound 
EE2 17alpha-ethynylestradiol 
EGTA Ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetra acetic acid 
ER Estrogen receptor 
FBS Fetal bovine serum 
GR Glucocorticoid receptor 
HR Hinge region 
HRE Hormone response elements 
HSP90 Heat shock protein 90 
IC50 Half maximal inhibitory concentration 
KE Key event 
LB Lysogeny broth 
LBD Ligand binding domain 
LOEC Lowest observed effect concentration 
LOD Limit of detection 
LOQ Limit of quantification 
LRA Luciferase reporter gene assay 
ME Matrix effect 
MIE Molecular initiating event 
NR Nuclear receptor 
NTD N-terminal domain 
ONP Ortho-nitrophenol 
ONPG Ortho-nitrophenyl-β-galactosid 
PBS Phosphate buffered saline 
POP Persistent organic pollutants 
PPCP Pharmaceuticals and personal care products 
PXR Pregnane X receptor 
RPM Revolutions per minute 
RXR Retinoid X receptor 
SEM Standard error of mean 
TBE Tris-borate-EDTA buffer 
TCPP Tris (1-chloro-2-propyl) phosphate 
UAS Upstream activation sequence 
VTG Vitellogenin 
WW Wastewater 
WWTPs Wastewater treatment plants 





Pharmaceuticals and personal care products are continuously released into the marine environment 
through wastewater. Understanding the possible biological implications of pharmaceuticals specifically 
may be particularly important as they are designed to be biologically active, and many of them are 
known ligands for nuclear receptors. Nuclear receptors are ligand-activated transcription factors and 
include a multitude of receptors such as the pregnane X receptor (PXR), androgen receptor (AR) and 
estrogen receptor (ER). PXR has an important role in regulation of enzymes responsible for 
biotransformation and transport of both xenobiotics and certain endogenous compounds. The AR and 
ER are vital in development and reproduction as they bind and mediate effects of androgens (e.g., 
testosterone) and estrogens (e.g., estrone). Common for these nuclear receptors is that they might bind 
both natural hormones and synthetic compounds such as several pharmaceuticals. The main goal of this 
thesis was to investigate the ability of mixtures of compounds present in wastewater and sludge to 
activate or inhibit zebrafish PXR, cod ARα and cod ERα. This was done by utilizing in vitro luciferase 
reporter gene assays where these receptors were exposed to sample extracts from wastewater influents, 
wastewater effluents, or sludge from five different wastewater treatment plants in Bergen, Norway. 
Additional targeted chemical analysis was conducted in order to establish what compounds were present 
in the samples. The reporter gene assays indicated the presence of PXR agonists in multiple wastewater 
influents and effluents, where several effluents clearly stood out as more potent activators. ARα 
activation was seen in fewer samples, although for both influents and effluents. No ERα activation was 
identified for any of the samples. Several wastewater extracts did however induce significant inhibition 
of cod ERα. None of the sludge samples activated any of the receptors. The targeted chemical analysis 
detected compounds at variable concentrations. Caffeine was detected at highest concentrations 
followed by acetaminophen, TCPP, and 5-H diclofenac for both influent and effluent samples. 
Additionally, metoprolol, carbamazepine, prednisolone, and octocrylene were detected at lower 
concentrations. Effluent from Knappen wastewater treatment plant (WWTP) was identified as the 
sample with highest total concentration of compounds. The findings of this thesis suggest that 
compounds and/or mixtures of compounds present in wastewater influents and effluents from WWTPs 
in Bergen, Norway can activate and inhibit certain nuclear receptors from zebrafish and Atlantic cod. 
The methods applied also uncovered elevated cytotoxicity in extracts where chemical analyses were 
inconclusive, implying that bioassays may work as a useful supplement to chemical analyses by 
indicating both biological activity and cytotoxicity of wastewater released into the environment. The 
thesis does however represent a narrow window of information. The targeted chemical analysis, singular 
sampling day and the three receptors chosen, provides only a compound specific, time specific, and 
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1.1 Contaminants of emerging concern 
The environment that all living organisms depends upon does not only have the nutrients and compounds 
needed to sustain life, but it also includes a multitude of chemical pollutants. These chemical pollutants 
may be categorized in various ways. One way to categorize them is by when they were taken into use 
and became apparent in the environment. Numerous persistent chemical contaminants that previously 
were abundantly used and released into the environment are now well-studied and called legacy 
contaminants (Landis, Sofield & Yu, 2018). The production and use of many of these compounds have 
been regulated and well managed, although many still persist in the environment (The Stockholm 
Convention, 2017). On the contrary, emerging contaminants are chemical pollutants that have been 
released into the environment more recently, which may lack both efficient regulations and thorough 
toxicity studies. However, there are no clear distinction, and a legacy contaminant may be of emerging 
concern due to current circumstances that are not yet properly studied. Due to this matter, Sauvé and 
Desroisers (2014) proposed that contaminants of emerging concern (CEC) may be a more appropriate 
term.  
For a compound to be classified as a CEC, the compound (either naturally occurring or manmade) must 
be suspected to pose a potential risk to organisms, as well as being poorly regulated (Sauvé, S., 
Desrosiers, 2014). Microplastics, brominated flame retardants (BFRs), per- and polyfluoroalkyl 
substances (PFAS), and pharmaceuticals and personal care products (PPCPs) can all be considered 
CECs (Landis, Sofield & Yu, 2018). 
 
1.1.1 Pharmaceuticals 
Pharmaceuticals are medicinal drugs used to prevent, treat, or relieve disease or symptoms of disease in 
humans and animals. They may also be given to sustain or re-establish physiological function. They are 
commonly taken orally or by inhalation, rectally, as an injection, or added to skin as ointment or a 
plaster. To understand why, how, and in what form pharmaceuticals are released into the environment, 
knowledge on the fate of these compounds when they enter our bodies, exerts their purpose, and 
eventually gets excreted is needed. 
The majority of pharmaceuticals influence chemical processes in specific cells, but they may work in 
different ways (Vennerød & Granås, 2021). In most cases however, to exert the desired effect, the 
pharmaceutical has to move from where it is administered to a receptor in a target site that stimulates a 
biological reaction (Eichhorn, 2013). Before the compound reaches the target site, it is influenced by 
several physical and biological processes within the organism, collectively known as pharmacokinetics. 
These processes include absorption, distribution, metabolism, and excretion, commonly abbreviated to 
ADME (Figure 1.1) (Eichhorn, 2013). When excreted, many pharmaceuticals are no longer in their 
original form. This is due to the metabolization – or biotransformation – that these compounds go 
through. As drugs are exogenous substances, the body will detect and attempt to excrete them as a 
defence mechanism. In this process, the liver is vital as it contains a number of enzymes with diverse 




Figure 1.1 Schematic illustration of the pathways of an orally administered pharmaceutical, and the 
relationship between pharmacokinetics and pharmacodynamics. After administration, the drug is absorbed 
(A) in the intestine. Distribution (D) to peripheral tissues and organs, as well as the liver, typically occurs via the 
bloodstream. Metabolism (M) commonly occurs in the liver and kidneys where more water-soluble metabolites 
are created. Excretion (E) happens through faeces, urine, and in some cases also through the lungs or the skin. 
Pharmacokinetics describes what the body does to the substance (the ADME-steps), whilst pharmacodynamics 
describes the biological response to the pharmaceutical. Illustration modified from Peter Eichhorn (2013). 
Cytochrome P450 enzymes (CYPs), such as members of the CYP1, CYP2, and CYP3 families, act as 
phase I oxidising enzymes and introduces polar groups to the xenobiotic compound (Kretschmer & 
Baldwin, 2005). In phase II, these more polar compounds are conjugated with an endogenous molecule, 
further promoting hydrophilicity for the metabolite to increase its ability to be excreted. The conjugation 
reaction usually includes conjugation to glutathione, sulfonation, glucuronidation, amino acid 
conjugation, or acetylation (Jancova, Anzenbacher, & Anzenbacherova, 2010). Enzymes responsible 
for phase II reactions are to a large extent transferases such as UDP-glucuronosyltransferases 
(UGTs/UDPGTs), sulfotransferases (SULTs), N-acetyltransferases (NATs), and glutathione S-
transferases (GSTs) (Jancova et al., 2010). Some proteins, such as members of the solute carrier (SLC) 
and ATP-binding cassette (ABC) families, act as phase III transporters that are responsible for carrying 
the metabolites across the cell membrane and into the blood stream, urine, and faeces. 
Through the biotransformation the xenobiotic is converted into a more water-soluble and excretable 
form and the metabolite can therefore diffuse/be transported from the liver into the bloodstream. 
Ultimately, this leads to glomerular filtration at the kidneys and excretion through urine. Another route 
of excretion is through faecal matter. This occurs either when the pharmaceutical is not completely 
dissolved and absorbed (and hence in an unchanged form), or due to biliary excretion (Eichhorn, 2013).  
As pharmacokinetics describes what the body does to the exogenous compound, pharmacodynamics 
describes what the compound does to the body. More specifically, it describes the mechanism of action 
of an exogenous compound. This involves the chemical interaction between the compound and the 
organism through e.g. receptors and enzymes (Øye & Brørs, 2021). Such an interaction may release a 
series of responses at multiple levels in the organism, from a cellular level to the whole organism. 
Further details on biological pathways will be covered in section 1.1.2 Adverse outcome pathways, 
whereas receptor interactions will be covered in section 1.2 Nuclear receptors.  
It is important to note that some pharmaceuticals are only partially or not systemically absorbed at all. 
A good example of this is clotrimazole which is a broad spectrum antimycotic drug commonly used to 
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treat dermal infections such as “athlete’s foot” (fungal feet infection) and yeast infections. Together with 
e.g. compounds used in anti-dandruff shampoos and sunscreens, these chemicals are released unchanged 
into our sewage water system when washed off our bodies. In areas where wastewater treatment systems 
are available, sewage containing either the original or metabolised compound ends up in wastewater 
treatment plants (WWTPs). 
WWTPs are not specifically designed to remove pharmaceuticals and a review conducted by Santos et 
al., 2010, found that efficiencies in removal of such compounds could vary with up to 99 %. In addition 
to this, the use of pharmaceuticals in Norway has in recent years increased, with a 2.7 % increment in 
defined daily doses (DDD) in 2020 compared to 2019 (Reseptregisteret, 2021). Assessing the possible 
environmental side effects of the release of pharmaceuticals through wastewater may therefore be of 
relevance. 
 
1.1.2 Adverse outcome pathways - AOP 
The environment that pharmaceutical-containing wastewater is released into is highly complex and can 
be studied at multiple biological levels. However, connecting scientific findings on a cellular level to 
organism, or even population responses, is demanding. Previously, experiments based on mortality, 
growth and reproduction were used to derive benchmark values when assessing potential adverse 
outcomes (Russom, Lalone, Villeneuve, & Ankley, 2014). This is highly expensive and ultimately leads 
to a relative low number of compounds being properly tested.  
The Adverse outcome pathway (AOP) is a framework proposed by Ankley et al. 2010, intended to 
enable mechanistic data to be linked to adverse outcomes at a higher biological level by using existing 
knowledge. A key application for AOPs is to provide both terminology and a way to structure knowledge 
from different biological levels that are relevant for risk assessment and management. This could enable 
a reduced need for expensive and time-consuming in vivo testing, and a greater use of new 
computational, molecular, and in vitro methods (Ankley et al., 2010). 
The first step in the AOP is the molecular initiating event (MIE), which also is recognized as the first 
key event (KE1). This step requires, or assumes, that the compound has been absorbed in the organism 
and distributed to the site of action. KE1 is characterised by e.g. receptor/ligand interaction, DNA 
binding, or protein oxidation (Ankley et al., 2010) . This marks the beginning of the toxicological 
pathway (Figure 1.2). KE2 involves the cellular response, and effects may involve gene activation, 
protein expression, altered signalling or protein depletion. Organ responses are in KE3. Here, altered 
physiology, disrupted homeostasis, or altered tissue development or function are direct effects. The 
organ responses may lead to organism responses (KE4), such as lethality, impaired development, or 
reduced fertility. Progressing from KE4 to KE5 represents the separation between traditional toxicology 
and environmental toxicology (Landis et al., 2018). Changes in population structure, recruitment, or 
even extinction of species may be direct outcomes (Ankley et al., 2010). Furthermore, community and 
ecological structures may be added. These were not included in the original framework, but has been 




Figure 1.2 Basic principles of an adverse outcome pathway (AOP). The pathway starts with the introduction 
of a chemical which leads to the molecular initiating event (MIE). This is also denoted as key event one (KE1). 
The AOP describes a total of five key events connecting molecular interaction to population response. Figure 
modified from (Landis, Wayne G., Sofield, Ruth M., Yu, 2018)  
As previously mentioned, the first step of the toxicological pathway is often the receptor/ligand 
interaction. In many cases, this interaction involves nuclear receptors.  
 
1.2 Nuclear receptors 
Endogenous signal molecules and some exogenous substances, such as pharmaceuticals or endocrine 
disrupting compounds (EDCs), can bind to receptors in cell membranes or within cells of an exposed 
organism. Nuclear receptors (NRs) are a family of ligand-activated transcription factors that recognises 
and binds specific ligands that regulate the expression of various genes involved in numerous 
physiological processes, such as metabolism and reproduction (Weikum, Liu, & Ortlund, 2018). NRs 
can be divided into seven nine subfamilies, from NR0 to NR8 (Huang et al., 2015; Wu, Niles, Hirai, & 
LoVerde, 2007). This thesis will focus on one member of subfamily 1; the pregnane X receptor - PXR, 
briefly mention one member of subfamily 2; the retinoid X receptor - RXR, and go in detail on three 
members of subfamily 3; the androgen receptor - AR, the estrogen receptor - ER and the glucocorticoid 
receptor - GR.  
NR1 members are regulated by lipophilic molecules such as thyroid hormones, bile acids and certain 
types of steroids (Weikum et al., 2018). NR2s are sometimes called orphan receptors where specific 
ligands important for regulation has not yet been determined, except for 9-cis retinoic acid for RXR 
(Weikum et al., 2018; Mangelsdorf & Evans, 1995). NR3s are receptors regulated by steroid hormones 
which derive from cholesterol. Due to the lipophilicity of these hormones they can pass the cell 
membrane by simple diffusion, and bind to the steroid hormone receptors located in the cytosol (Beato 
& Klug, 2000). The ligand binding to the receptor induces a conformational change and translocation to 
the nucleus where regulation of target genes occurs. 
Although belonging to the same superfamily, these receptors all work differently and have their own 
unique role within the cell. However, most NRs have the same general structure (Figure 1.3)(Weikum 
et al., 2018). At one end, we find the N-terminal domain (NTD). The NTD varies highly, but all contains 
the activator function-1 region (AF-1) which is responsible for interaction with regulatory proteins 
(Weikum et al., 2018). The DNA-binding domain (DBD) is located next to the NTD and holds a short 
motif (P-box) that binds to specific DNA sequences known as response elements (Robinson-Rechavi, 
Garcia, & Laudet, 2003). The DBD also contains a D-box involved in the heterodimerization and 
homodimerization of the NRs. (Pawlak, M., Lefebvre, P., Staels, 2012). The DBD in NRs is constructed 
of two zinc fingers which enable DNA binding (Franco, Li, & Wei, 2003).  Between DBD and the ligand 
binding domain (LBD), there is a hinge region (HR), which is highly flexible and plays an important 
role in the orientation of the DBD and LBD. Finally, we have the ligand binding domain. The LBD is 
the site where lipophilic ligands that either activate or repress the transcriptional activity of the receptor 
may bind. The specific site of binding is called the ligand binding pocket (LBP) and varies between the 
different receptors (Pawlak, Lefebvre & Staels, 2012). The activator function-2 region (AF-2), which is 
found in the LBD is, compared to AF-1, highly structured and ligand dependent (Wärnmark, Treuter, 
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Wright, & Gustafsson, 2003). Coactivators that are ligand dependent have been shown to bind to the 
AF-2, and most of these have a consensus sequence (LXXLL) providing stability to this interaction 
(Wärnmark et al., 2003).  
 
Figure 1.3 The functional domains of nuclear receptors. N-terminal domain (NTD) with AF-1, DNA-binding 
domain (DBD), a hinge region (HR) and the ligand-binding domain (LBD) with AF-2. Illustration based on 
Weikum, Liu, and Ortlund 2018. 
As well as this common general structure, all nuclear receptors, as their name suggests, are in one way 
or another involved with the cell nucleus. Yet, their localization in the cell and operational mechanism 
varies. Based on this, they are often divided into four different types: I, II, III and IV (Weikum et al., 
2018)(Figure 1.4). 
 
Figure 1.4 Three types of nuclear receptors. Type I nuclear receptors, such as AR, ER and GR, are present in 
cytosol upon ligand binding. Type II and Type III nuclear receptors, such as PXR and RXR, are present in nucleus. 
Type IV nuclear receptors are monomeric orphan receptors also present in cell nucleus upon ligand binding (not 
included in this thesis). Illustration modified from Weikum et al., 2018.  
 
Type I includes steroid receptors (the NR3 subfamily). Receptors of this type are found in the cytoplasm 
where they are bound to chaperones. When a ligand binds, the receptor-ligand complex forms a homo- 
or heterodimer (with RXR) and gets translocated to the nucleus where it binds to hormone response 
elements (HRE) in the DNA. Type II includes members of NR1 subfamily which usually forms 
heterodimers with RXR. These are found in the nucleus where co-repressors are exchanged with co-
activators upon ligand-binding. Type III includes members of NR2 subfamily and have similar 
mechanisms to Type II receptors. The main difference here is that the members of Type III form 





1.2.1 The androgen receptor (AR) 
The androgen receptor (AR, NR3C4) is a steroid hormone receptor and a member of the NR3 subfamily 
of NRs. It is expressed in a wide range of organs and have been found to have a significant role in 
reproduction, muscle and bone development and maintenance, and in the immune system (Davey & 
Grossmann, 2016; Rana, Davey & Zajac, 2014) The AR binds androgens such as testosterone, 
dihydrotestosterone (DHT), and synthetic compounds with testosterone-like properties, such as the 
anabolic steroid nandrolone (Figure 1.5) (Neal, 2016). These androgens are key in male development 
and fertility as well as responsible for some secondary puberty changes in females (Øye & Borén, 2018). 
Just like the other nuclear receptors, AR contains an N-terminal domain, a DBD, a hinge region and an 
LBD. Unliganded, the AR is found as a monomer in the cytosol bound to heat shock proteins (HSP90 
chaperones). When an androgen binds to the LBD, the AR changes conformation, forms homodimers, 
and translocates to the nucleus where androgen response elements (AREs) are detected in the genomic 
DNA (Feng, Qin, He, 2019). Here, coactivators are recruited, and transcription of target genes will 
follow.  
A           B      C  
Figure 1.5 2D structure of some AR ligands. (A) Testosterone (PubChem CID 6013), (B) dihydrotestosterone 
(PubChem CID 10635), and (C) nandrolone (PubChem CID 9904). 
One known target gene of the AR is probasin, which is a prostate-specific gene responsible for directing 
the production of the protein probasin which is found in the epithelium of the prostate (Johnson, 
Hernandez, Wei, & Greenberg, 2000) (“Probasin,” 2008). Studies treating human prostate cancer cell 
line (LNCaP) with the synthetic androgen R1881, also found that androgen treatment induced several 
other genes involved in the production of prostatic fluid, as well as prostate-specific antigen (PSA), 
sorbitol dehydrogenase and vascular endothelial growth factor (VEGF) (DePrimo et al., 2002), further 
emphasizing its significance in male reproduction. Androgen disrupting chemicals has been found to 
reduce sperm counts and lead to decreased fertility and testicular and prostate cancer (Luccio-Camelo 
& Prins, 2011). 
Concentration of androgens are significantly lower in females, although they are important in both 
female development and fertility (Dart, Waxman, Aboagye & Bevan, 2013). A vital role of androgens 
in females is as a substrate for the aromatization of androgens to estrogens, although the AR is indeed 
expressed in female tissues such as the mammary gland, uterus and in ovarian follicles as well (Dart et 
al., 2013; Sen & Hammes, 2010). In female mice, androgens have been found to cause AR induction 
and expression of miR-125b, a micro-RNA gene which leads to suppression of follicular atresia (the 
breakdown of ovarian follicles), indicating a regulatory role in female reproduction (Sen et al., 2014). 
However, elevated levels of testosterone in human females have been linked to polycystic ovarian 
syndrome (PCOS) causing reduced fertility (Rosenfield & Ehrmann, 2016). 
The AR is found across a multitude of invertebrate (Köhler et al., 2007), and vertebrate species, 
including fish, where two AR subtypes are known (Douard et al., 2008; Ikeuchi, Todo, Kobayashi, & 
Nagahama, 2001; Takeo & Yamashita, 1999). AR is also found in Atlantic cod (Gadus morhua), 
(LaLone et al., 2013) (Marta Eide et al., 2018). 11-ketotestosterone is an important androgen in fish 
(Kortner, Rocha, & Arukwe, 2009) which is also found to activate human AR in vitro (Imamichi et al., 
2016).  
In addition to natural ligands, AR in various species can be activated by synthetic compounds (see 
Appendix, Table 1) such as the flame retardant TBECH (Pradhan, Kharlyngdoh, Asnake, & Olsson, 
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2013) and the pharmaceutical dexamethasone (Y. Park, Park, & Lee, 2021). Synthetic compounds 
known to inhibit AR (Appendix, Table 2) includes pharmaceuticals such as flutamide (Martinović-
Weigelt et al., 2011) and the plastic additives bisphenol A, S and F (Ekman et al., 2012; C. Park et al., 
2020) Although AR is regarded as well conserved across species, differences can be observed in binding 
affinities for certain compounds (Wilson, Cardon, Gray Jr., & Hartig, 2007; Wu et al., 2010).  
 
1.2.2 The estrogen receptor (ER) 
The estrogen receptors (ER, NR3A1, NR3A2) are steroid hormone receptors and members of the NR3 
subfamily of nuclear receptors. The ER binds estrogens like 17β-estradiol (E2) and the synthetic 
estrogen ethynylestradiol (EE2) (Figure 1.6). Many estrogens, such as estradiol, are lipophilic and 
protein-bound in the blood. This means that only when disassociating from these proteins enables them 
to diffuse easily through the cell membrane (Mueller & Korach 2005). The unliganded estrogen receptor 
is located as a monomer in the cytoplasm and bound to heat-shock proteins. Upon binding of a ligand, 
the heat-shock proteins are displaced, and the ER creates homodimers before binding the estrogen 
responsive elements on the DNA in the cell nucleus. This results in the transcription of the specific target 
gene mRNAs, which ultimately leads to translation into the corresponding proteins (Mueller & Korach, 
2005).  
A           B           C  
Figure 1.6 2D structure of ER ligands. 17β-estradiol/E2 (A) (PubChem CID 5757), Ethynylestradiol/EE2 (B) 
(PubChem CID5991), tamoxifen (antagonist) (C) (PubChem CID 2733526). 
 
Estrogens and the estrogen receptors are essential in development and fertility. Research done on rats 
and mice indicates that a disruption in ERα causes infertility in both males and females, whilst disruption 
in ERβ causes infertility in females only (Rumi et al., 2017). The pS2/TFF1 (trefoil factor 1 protein, 
present in gastrointestinal mucosa) gene was one of the first genes demonstrated to be controlled by 
estrogen at a transcriptional level (Brown, Jeltsch, Roberts, & Chambon, 1984). Other well-known target 
genes of ERα are cathepsin D (CATD), and c-Myc (Shang, Hu, Direnzo, Lazar, & Brown, 2000). C-
myc is of particular interest as it is regarded an oncogene (cancer-promoting) which stimulates both cell 
cycle progression and proliferation (Wang et al., 2011).  
Estrogen receptors have been identified in a multitude of vertebrates such as human (Green et al., 1986), 
rat (Koike, Sakai, & Muramatsu, 1987), and Atlantic cod (Goksøyr, Sørensen, Grøsvik, Pampaning, 
Goksøyr & Karlsen, 2021). The receptors have also been found in some invertebrates such as molluscs 
(Hultin et al., 2014), annelids (Keay & Thornton, 2009), and rotifers (Jones et al., 2017) (Cuvillier-Hot 
& Lenoir, 2020). In Atlantic cod, three estrogen receptors have been identified, cod ERα (NR3A1), cod 
Erβ-I (NR3A2), and cod Erβ-II (NR3A3) (Nagasawa, Presslauer, Kirtiklis, Babiak, & Fernandes, 2014).  
ER activation by synthetic estrogens in fish is closely linked to the expression of vitellogenin (Vtg), 
which is the precursor for yolk proteins in oviparous vertebrates (Oppen-Berntsen, Hyllner, Haux, 
Helvik, & Walther, 1992), making it a suitable indicator of environmental estrogen exposure in male 
fishes. Synthetic estrogens known to activate ER (in various species) includes the makeup and plastic 
additive benzophenone (Schreurs, Sonneveld, Jansen, Seinen, & van der Burg, 2005), the UV-filter 
octocrylene (Kunz & Fent, 2006b) and the synthetic hormone EE2 (Notch & Mayer, 2011). Compounds 
known to inhibit ER includes the antibacterial and antifungal compound triclosan (Ahn et al., 2008), the 
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pharmaceutical tamoxifen (Miksicek, 1994), and the polycyclic musk AHTN (Schreurs et al., 2005), 
among others (Appendix, Table 3 & 4). 
 
1.2.2 The glucocorticoid receptor (GR) 
The third, and last, steroid hormone receptor covered by this thesis is the glucocorticoid receptor (GR, 
NR3C1). GR binds glucocorticoids synthesised by the adrenal cortex which are involved in functions 
such as metabolism, growth, and development. The receptor is expressed in almost all vertebrate cells 
(Weikum et al., 2017). Glucocorticoids such as dexamethasone and prednisolone (Figure 1.7) are also 
used clinically to treat inflammation and autoimmune diseases in humans. Just like the other nuclear 
receptors, the GR has the same structural domains and is associated with chaperone proteins such as 
hsp70 and hsp90 (McEwan & Kumar, 2015). Upon ligand binding the GR undergoes a conformational 
change, separation from its chaperones and translocation to the cell nucleus where it binds the 
glucocorticoid response elements (GREs). This either leads to an activation or repression of target genes. 
A            B            C  
Figure 1.7 2D structure of GR ligands. Cortisol (A) (PubChem CID 5754), Dexamethasone (B) (PubChem CID 
5743), Prednisolone (C) (PubChem CID 5755). 
The target genes of the GR includes (among others) genes involved in antiinflammation (Wang et al., 
2004), and genes regulating circadian rhythm. This was shown by an increased transcription level of 10 
known core clock components following dexamethasone exposure in mice (So, Bernal, Pillsbury, 
Yamamoto, & Feldman, 2009). The glucocorticoid receptor has been identified in a multitude of 
vertebrates such as humans (Hollenberg et al., 1985; Rupprecht et al., 1993), rats (Funder, Feldman, & 
Edelman, 1973), and teleosts, including Atlantic cod (Hori, Rise, Johnson, Afonso, & Gamperl, 2012; 
Kleppe et al., 2013).  
The GR has in recent years gained increased attention as a possible target for EDCs (Zhang, Yang, Liu, 
Schlenk, & Liu, 2019). The EDCs bisphenol A, dicyclohexyl phthalate, endrin (pesticide) and 
totylfluanid (fungicide) has been identified as activators of human GR in vitro (Sargis, Johnson, 
Choudhury, & Brady, 2010). Certain members of the flame retardant class polybrominated diphenyl 
ethers (PBDEs) have also been shown to be antagonists in human GR (Zhang, Wang, Zhu, Liu, & Zhao, 
2017) (Appendix, Table 5.). 
 
1.2.4 The pregnane X receptor (PXR) 
The pregnane X receptor (PXR, NR1I2) is a nuclear receptor belonging to the type II nuclear receptors. 
Upon ligand binding it goes through conformational change and forms heterodimers with the retinoid X 
receptor (RXR). The PXR is found in the nucleus where co-repressors are exchanged with co-activators 
upon ligand-binding. When bound, the PXR can induce expression of a number of genes responsible for 
metabolization, oxidation, conjugation and transport of both xenobiotics and endogenous substances 
(Kliewer, Goodwin, & Willson, 2002). This is important as the receptor may bind both xenobiotics as 
well as possible harmful endogenous compounds such as bile acids (Kliewer et al., 2002). More 
specifically, enzymes induced through PXR activation include CYP2B, 2C and 3A (Klaassen & 
Watkins, 2015). The role of CYPs in metabolization of xenobiotics such as pharmaceuticals is described 
in more detail in part 1.1.1 Pharmaceuticals.  
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Due to the structurally wide range of ligands (Appendix, Table 6), the receptor is also commonly referred 
to as a promiscuous receptor. PXR agonists include compounds such as the plastic additive bisphenol A 
(Takeshita et al., 2001), the pharmaceuticals clotrimazole, carbamazepine (Lille-Langøy et al., 2015) 
and dexamethasone (Pacussi, Drocourt, Fabre, Maurel & Vilarem, 2000), and the antibiotic rifampicin 
(Lille-Langøy et al., 2015) (Figure 1.8), just to mention a few. Although multiple PXR agonists are 
known, very few antagonists have been reported, with the fungicide ketoconazole being the most 
researched one (H. Huang et al., 2007; Takeshita, Taguchi, Koibuchi, & Ozawa, 2002). 
A            B            C  
Figure 1.8 2D structure of some known PXR ligands. Clotrimazole (A) (PubChem CID 2812), Rifampicin (B) 
(PubChem CID 135398735), Carbemazepine (C) (PubChem CID 2554) 
 
The PXR has been identified in humans (Kliewer et al., 1998), and numerous vertebrates such as 
zebrafish (Bainy et al., 2013), pigs (Moore et al., 2002), and polar bears (Lille-Langøy et al., 2015). 
However, studies have indicated significant cross-species variations in PXR ligand specificity, 
especially when comparing mammalian PXRs to avian and zebrafish PXR (Ekins, Reschly, Hagey, & 
Krasowski, 2008; Krasowski, Ni, Hagey, & Ekins, 2011). Additionally, research on mammalian PXR 
has found key differences between human and mouse PXR and the agonistic activities of 200 pesticides 
by using in vitro reporter gene assays (Kojima, Sata, Takeuchi, Sueyoshi, & Nagai, 2011). Even within 
the same species, variations have been found, as those identified in zebrafish by Lille-Langøy et al., 
2019. Interestingly, the PXR has been found to be present in e. g. zebrafish, but absent in Atlantic cod, 




The first manifestations of toxicity are the cellular responses (Fent 2001), and these can be investigated 
with bioassays. By using bioassays, ligand–receptor interactions can also be studied, and provide key 
knowledge on the first step in the toxicological pathway, the MIE. Additionally, bioassays can be used 
to measure the biological activity of complex mixtures of both known and unknown chemicals, even at 
low concentrations (Leusch et al. 2018). Bioassays may also contribute with knowledge on the potency 
of a contaminant or mixture of contaminants, which is particularly important as the most abundant 
contaminants are not necessarily the most biologically active ones (Brack et al. 2005). By increasing the 
use of in vitro (cells or tissue outside the living organism) methods, it could result in a decreased use of 
bioindicator organisms in environmental monitoring (Pérez-Albaladejo et al. 2016) and thereby 
contribute positively to the 3R principle of replacement, reduction, and refinement of animal testing. 
The luciferase reporter gene assay (LRA) is a well-established method used to investigate molecular 
interactions in a cell. 
 
1.3.1 Luciferase reporter gene assay (LRA) 
Luciferase reporter gene assay (LRA) is one commonly applied bioassay-principle in environmental 
toxicology as it can be utilized to determine if a substance can activate or inhibit a certain receptor. The 
assay is based on luciferase, which is an enzyme originally used for bioluminescence in fireflies (Brasier, 
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Tate, & Habener, 1989). Cells are cultivated and transfected with both receptor plasmids and a reporter 
plasmid containing the luciferase gene. When an agonistic ligand binds to the nuclear receptor 
investigated, a conformational change will occur, activating the transcription of the luciferase gene, and 
ultimately translation of the enzyme luciferase. Luciferase oxidates luciferin into oxyluciferin which is 
a process creating a light signal, which can be quantified (a detailed description can be found in Methods 
3.2.3). The assay has been used in research on numerous nuclear receptors from various species, such 
as human AR (Ermler, Scholze, Kortenkamp, 2011), cod ARα and cod ERα (Goksøyr, Sørensen, 
Grøsvik, Pampaning, Goksøyr , Karlsen, 2021) and zebrafish PXR (Lille-Langøy et al., 2019). 
Ultimately, the LRA can give us an indication about whether a particular receptor could be activated or 
antagonized by a compound or mixture of compounds. 
 
1.3.2 Zebrafish and Atlantic cod as model species 
Zebrafish (Danio rerio) is a small freshwater fish species belonging to the family Cyprinidae, and is 
native to waters in India, North Pakistan, Nepal, Bhutan and South Asia (Jagdale, Hude, & Chabukswar, 
2020). It is frequently used as an animal model and is popular in both toxicology and biomedical 
research. Initially, its popularity was due to its small size, fast development, short generation time, their 
embryonic and larval transparency, and rapid hatching time (Chakraborty, Sharma, Sharma, & Lee, 
2016). As more research has been done on this species, its genome has been sequenced, and several 
important physiological homologies with humans have been identified (Jagdale et al., 2020)(Hsu, Chi-
Hsin, Wen, Zhi-Hong, Lin, Cha-Shing, Chakraborty, 2007).  
Atlantic cod (Gadus morhua) is a marine teleost with a wide distribution in the North Atlantic Ocean 
and the Barents Sea (Figure 1.9). Due to its presence and position in the coastal marine food chain and 
ecosystem, it is regarded both as an important species ecologically, but also as an indicator species in 
pollution monitoring programs and in the Protection of the Marine Environment of the North-East 
Atlantic (OSPAR) convention  (OSPAR Commission, 2009). The genome of the Atlantic cod was first 
sequenced and annotated in 2011 (Star et al., 2011) and new and updated genome assemblies have been 
added later. In recent years the species has been used as an indicator species when investigating 
biological consequences of produced water exposure (Sundt et al., 2012), capped waste disposal sites 
(Dale et al., 2019) and contaminated sediments (Goksøyr et al. 2021).  
 
Figure 1.9 Distribution of Atlantic cod (red). Illustration from FAO (2021).  
 
1.4 Pharmaceuticals as possible environmental stressors 
Norway has the second longest coastline in the world, with a total length of 100,915 km (Regjeringen, 
2015). Along this coastline, and by some freshwater lakes and rivers, more than 2500 municipal 
wastewater treatment plants (WWTP) are located.  A majority of these were built between 1970 – 1985, 
and the treatment goal is removal of organic matter, and not necessarily contaminants. Additionally, 500 
planned treatment plants are not yet built (Norwegian Environmental Agency, 2021). This means that 
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for about 350,000 people in Norway, wastewater is released untreated into the environment. The general 
rule is also that ships may release untreated sewage 300 m from land (except some stricter rules in 
certain fjords and highly trafficked areas) (Norwegian Maritime Authority, 2016), further contributing 
to the release of wastewater into Norwegian waters. As previously mentioned, pharmaceutical usage is 
on the rise, and an inevitable consequence of this is higher levels of pharmaceuticals being discharged 
into the environment (Corcoran, Winter, & Tyler, 2010). Even for pharmaceuticals regarded as easily 
degradable, it can be argued that their continuous input into the environment makes them “pseudo 
persistent” (Trombini, Hampel, & Blasco, 2019). With this, more knowledge on possible environmental 
consequences is needed. 
The topic has received increased attention the past decades, with research demonstrating outcomes such 
as collapse in a fish population following synthetic estrogen exposure (Kidd et al., 2007), and androgens 
in wastewater causing masculinization in female mosquitofish (Huang et al., 2019). Extensive reviews 
have also reported on an increase in research in the field, but still a general lack of knowledge on 
pharmaceutical mixtures and ecotoxicological impacts (Mezzelani, Gorbi, & Regoli, 2018). 
Zebrafish PXR, cod ARα, and cod ERα have all previously been utilized to assess the presence of 
contaminants in several places, including in Bergen, Norway. Human and zebrafish nuclear receptors 
have also been used in in vitro bioassays on wastewater and surface water extracts (Neale, Grimaldi, 
Boulahtouf, Leusch, & Balaguer, 2020) where wastewater-based chemicals such as pharmaceuticals 
have been found to have a higher affinity to zebrafish PXR compared to human PXR (Neale, Grimaldi, 
et al., 2020). Research on Norwegian WWTPs using these receptors specifically has not yet been 
reported.  
 
1.5 Aim of the study 
This master thesis aims to investigate the utility of a set of receptor-based in vitro bioassays in detecting 
and monitoring the potency of pharmaceuticals released from WWTPs in Bergen, Norway. Additionally, 
the study aims at evaluating potential differences in wastewater treatment methods with respect to the 
efficient removal of pharmaceuticals.  
The receptors chosen are from both zebrafish (PXR) and Atlantic cod (ARα, ERα and GR). These 
receptors are important in a wide array of biological processes, such as the biotransformation of 
xenobiotics for PXR, development and reproduction for ERα and ARα, and growth and immune 
responses for GR. This means that any receptor activation or inhibition detected also identifies a 
molecular initiating event (MIE) with potential adverse biological impacts.  
In order to investigate this, the following experiments were planned: 
- Extraction and analysis of pharmaceuticals and personal care products in wastewater and sludge 
samples from five different WWTPs in Bergen (both before and after treatment) 
- Investigation of the cytotoxic properties of the extracts using a cell viability assay 
- Utilizing luciferase gene reporter assays in vitro to investigate whether PPCPs or other 
compounds present in wastewater or sludge samples may possess agonistic or antagonistic 
effects on the following receptors:  
o Zebrafish PXR-TL 
o Atlantic cod ARα 
o Atlantic cod ERα 








Table 2.1. Overview of used chemicals with chemical formula and supplier/product number 
Name Chemical formula Supplier/product number 
10x loading buffer  TaKaRa/9157 
2-log DNA ladder  New England Biolabs 
2-β mercaptoethanol C2H6OS Sigma-Aldrich/M6250 
5-Carboxyfluorescein Diacetate, 
Acetoxymethyl Ester (5-CFDA, 
AM) 
C25H16O9 Thermo Fischer 
Scientific/C1354 
Adenosine 5′-triphosphate 
disodium salt trihydrate (ATP) 
C10H20N5Na2O16P3 Sigma-Aldrich/A2383 
Agar-agar  Merch Millipore/101614 
Agarose  Sigma-Aldrich/A9539 
Ampicillin sodium salt C16H18N3NaO4S Sigma-Aldrich/A9518 
Boric acid H3BO3 Merch Millipore/100165 
Bovine serum albumin (BSA)  Sigma-Aldrich/A9647 
Calcium chloride dihydrate CaCl2 · 2H2O Merch Millipore/102382 
CHAPS C32H58N2O7S Thermo Fisher/28299 
Coenzyme A trilithium salt C21H33Li3N7O16P3S Sigma-Aldrich/C3019 
Dimethyl sulfoxide (DMSO) (CH3)2SO Sigma-Aldrich/D8418 
Disodium hydrogen phosphate 
dihydrate 
Na2HPO4 · 2H2O Sigma-Aldrich/30435-M 
DL-Dithiothreitol (DTT) HSCH2CH(OH)CH(OH)CH2SH Sigma-Aldrich/D0632 
D-luciferin Firefly C11H8N2O3S2 Biosynth/L-8200 
Dulbecco’s Modified Eagle 
medium (with phenol red) 
 Sigma-Aldrich/D5671 
Dulbecco’s Modified Eagle 
medium (without phenol red) 
 Sigma-Aldrich/D1145 
Erythrosine B C20H6I4Na2O5 Sigma-Aldrich/200964 
Ethanol CH3CH2OH Sigma-Aldrich/34852 
Ethylene glycol-bis(2-
aminoethylether)-N,N,N′,N′-
tetraacetic acid (EGTA) 
[-CH2OCH2CH2N(CH2CO2H)2]2 Sigma-Aldrich/E3889 
Ethylenediaminetetraacetic acid 
disodium salt (EDTA) 
C10H14N2Na2O8  Merch Millipore/108418 
Fetal bovine serum (FBS)  Sigma-Aldrich/F7524 
Galactose C6H12O6  
GelRed ®  C60H72I2N8O5 Biotium/41003 
Glycerol HOCH2CH(OH)CH2OH Sigma-Aldrich/G5516 
Isopropanol (CH3)2CHOH Kemetyl/603-117-00-0 
L-α-phosphatitylcholine  Sigma-Aldrich/P3644 
L-glutamine H2NCOCH2CH2CH(NH2)CO2H Sigma-Aldrich/G7513 
Magnesium carbonate hydroxide 
pentahydrate 
(MgCO3)4 · Mg(OH)2 · 5H2O Sigma-Aldrich/G7513 
Magnesium chloride MgCl2 Sigma-Aldrich/M8266 
Magnesium chloride hexahydrate MgCl2 · 6H2O Sigma-Aldrich/M9272 
Magnesium sulfate MgSO4 Sigma-Aldrich/M2643 
Magnesium sulfate heptahydrate MgSO4 · 7H2O Sigma-Aldrich/63145 














Phosphate buffered saline (PBS)  Sigma-Aldrich/P5493 
Potassium Chloride KCl Sigma-Aldrich/C3019 
Potassium Phosphate monobasic KH2PO4  Merch Millipore/529568 
Resazurine sodiumsalt C12H6NNaO4 Sigma-Aldrich/R7017 
Sodium chloride  NaCl Merch Millipore/106404 
Sodium dihydrogen phosphate 
monohydrate 
NaH2PO4 · H2O Merch Millipore/106346 
Sodium pyruvate  C3H3NaO3 Sigma-Aldrich/S8636 
Super Optimal broth with 
catabolite repression (SOC) 
 New England 
Biolabs/B9020S 
TransIT®-LT1  Mirus/MIR2300 
Tricine (HOCH2)3CNHCH2CO2H Sigma-Aldrich/T0377 
TritonTM X-100 t-Oct-C6H4-(OCH2CH2)xOH Sigma-Aldrich/X100 
Trizma ® base NH2C(CH2OH)3 Sigma-Aldric/T1503 
Trizma® phosphate dibasic (C4H11NO3)2 · H3PO4 Sigma-Aldrich/T4258 
Trypsin-EDTA solution 1x 
(0,05% trypsin, 0,02% EDTA) 
 Sigma-Aldrich/59417c 
Trypton  Merch Millipore/111931 
Yeast extract  Fluka/92144 
 
 
2.2 Plasmid preparation  
2.2.1 Commercial kits 
Table 2.2 Kit used for plasmid preparation 
Name Usage Supplier 
NucleoBond© plasmid 
purification kit 
Plasmid prep (Midi-prep) Macherey-Nagel 
 
2.2.2 Prepared plasmids 
Table 2.3 Overview of plasmids 
Plasmid Reporter gene system 
(MH100)x4 tk luc Reporter plasmid Gal4/UAS-based 
pCMV-β-Gal Control plasmid 
pCMX-Gal4-ARα (cod) Receptor plasmid 
pCMX-Gal4-ERα (cod) Receptor plasmid 
pCMX-Gal4-GR (cod) Receptor plasmid 
pCMX-Gal4-PXR-TL (zebrafish) Receptor plasmid 
 
 
2.3 Cell lines 
Table 2.4 Overview of cell lines 
Cell lines Description 
StrataClone SoloPack competent cells Escherichia coli (procaryote) 
COS-7-cells African green monkey kidney cells (eucaryote) 
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2.4 Cell growth media 
Table 2.5 Lysogeny broth (LB) medium 
Components LB medium (concentration) LB-agar (concentration) 
Agar-agar - 15 g/l 
Ampicillin* - 100 mg/l 
MilliQ water - - 
Sodium chloride 10 g/l 10 g/l 
Tryptone 10 g/l 10 g/l 
Yeast extract 5 g/l 5 g/l 
Solution autoclaved 
* Added post autoclavation 
 
Table 2.6 Cell freezing media for COS-7 cells 
Component Concentration 
Dulbecco’s modified Eagle medium (DMEM) 
w/phenol red  
1X 
Fetal bovine serum (FBS) 10% 
L-glutamine 4 mM 
Sodium pyruvate  1 mM 
Penicillin-Streptomycin  100 u/mL 
Dimethyl sulfoxide (DMSO) 5% 
 
Table 2.7 Growth media for cultivation of COS-7 cells 
Component Concentration 
Dulbecco’s modified Eagle medium (DMEM)* 1X 
Fetal bovine serum (FBS)** 10% 
L-glutamine 4 mM 
Sodium pyruvate 1 mM 
Penicillin-Streptomycin 100 u/mL 
*DMEM w/phenol red used for growth media, DMEM w/o phenol red used during exposure 
** Charcoal stripped FBS in exposure media 
 
 
2.5 Buffers and solutions 
2.5.1 Agarose gel electrophoresis  
Table 2.8 TBE buffer (tris borate EDTA) 5X 
Components Concentration 
Trizma base 0.45 M 
Boric acid 0.45 M 
EDTA 0.01 M 
H20 - 
 
Table 2.9 TBE agarose gel 
Component Concentration 
TBE buffer (Table 2.8) 0.5 X 
Agarose 0.70 % 




2.5.2 Solutions for luciferase reporter gene assay ligand activation 
Table 2.10 Cell lysis base buffer (1X) 
Component Concentration 






Table 2.11 Cell lysis reagent solution 
Component  Concentration 
Lysis base buffer (Table 2.10) 1 X 
EGTA 4 mM 
MgCl2 8 mM 
PMSF 0.4 mM 
DTT 1 mM 
 
Table 2.12 β-galactosidase base buffer (10X) 
Component Concentration 
Na2HPO4  60 mM 
NaH2PO4 40 mM 
KCl 10 mM 
MgCl2  1 mM 
 
Table 2.13 β-galactosidase reagent solution 
Component Concentration 
β-galactosidase buffer 1X (Table 2.12) 1 X 
β-mercaptoethanol 52.9 mM 
ONPG 8.6 mM 
 
Table 2.14 Luciferase base buffer (4X, pH 7.8) 
Components Concentration 
Tricine 80 mM 
(MgCO3)4 • Mg(OH)2 • 5H2O 4.28 mM 
EDTA 0.4 mM 
MgSO4 10.68 mM 
 
Table 2.15 Luciferase reagent solution 
Component Concentration 
Luciferase base buffer (Table 2.14) 1 X 
ATP 0.5 mM 
DTT 5 mM 
CoA* 0.2 mM 
D-luciferin* 0.5 mM 





2.5.3 Cell viability 
Table 2.16 L-15/ex Solution 1 
Component Concentration 
NaCl 133.33 g/l 
KCl 6.67 g/l 
MgSO4 • 7H2O 3.33 g/l 
MgCl6 • 6H2O 3.33 g/l 
H2O - 
 
Table 2.17 L-15/ex Solution 2 
Component Concentration 
CaCl2 1.4 g 
Deionized-H2O 100 mL 
 
Table 2.18 L-15/ex Solution 3 
Component Concentration 
Na2HPO4 1.9 g 
KH2PO4 0.6 g 
Di-H2O 300 mL 
 
Table 2.19 L-15/ex solution for cell viability measurement 
Component Concentration 
Solution 1 (Table 2.16) 34 mL 
Solution 2 (Table 2.17) 6 mL 
Solution 3 (Table 2.18) 17 mL 
Galactose 90 0.8 mL 
Pyruvate 0.5 mL 
Di-H20 500 mL 
 
Table 2.20 Resazurin and CFDA-AM viability solution 
Component Concentration 
L-15/ex (Table 2.19) 1 X 
Resazurin 0.03 mg/mL 
CFDA-AM 0.001 mM 
 
2.6 Instruments 
Table 2.21 Instruments used 
Instrument Application Supplier 
Bürker haemocytometer Counting COS-7 cells Marienfield 
ChemiDOCTM XRS+ System Gel scanning Bio-Rad 
EnSpire 2300 Multimode 
Reader 
Plate reader PerkinElmer  
HS 501 Digital Platform shaker IKA-Werke 
NanoDrop 1000 Spectrophotometer Thermo Scientific 
PowerPacTM HC Power supply Bio_Rad 
Aeros multifuse X3R Centrifuge Thermo Scientific 
Panasonic mco-170aicuv-pe Incubator Lab-Tec 





Table 2.22 Software used 
Software Application Supplier 
EnSpire Manager Plate reader operation PerkinElmer 
Excel 2020 Data analysis and statistics Microsoft 
GraphPad Prism 7 Figures and statistics GraphPad 
Mendeley Literature citation Elsevier 
PowerPoint 2020 Processing of figures Microsoft 
 
2.8 Ligands used in luciferase reporter gene assay  
Table 2.23 Ligands used in LRA. All structures from chemspider.com 















































































3.0 Experimental outline 
 
Figure 3.1 Experimental outline. Samples were taken from five different wastewater treatment plants in Bergen, 
Norway, and extracted by Ivo Havranek, postdoc at NMBU by using Oasis HLB-disks. Plasmids, including AR, 
ER and PXR, were prepared and transfected into COS-7 cells seeded in 96-well plates. The transfected COS-7 
cells were exposed to wastewater or sludge extracts for 24 hours prior to luciferase activity measurement, or 













3.1 Collection and treatment of samples 
3.1.1 Wastewater samples 
Samples (2 litres) were taken before and after treatment for the five treatment plants (Table 3.2). The 
sampling was based on a 24-hour accredited method conducted by trained and contracted personnel 
from BergenVann. For 24-hour accredited sampling a multitude of samples are taken from the 
wastewater stream in a set interval for 24 hours. These samples are continuously added to a pool, which 
constitutes a representative fraction of the wastewater stream for the past 24 hours. The room in which 
the pool is stored is kept at < 5°C. All samples are accredited according to this method, except samples 
taken from Kvernevik due to slightly increased room temperatures (5 – 7 °C) during sampling. This is 
not expected to influence the results.  
All samples before treatment (influents, named station name + in) are completely unprocessed sewage 
and wastewater (Stage 1, Figure 3.3 - 3.5), whilst samples taken after treatment (effluents, named station 
name + out) have been treated according to the respective treatments at the given WWTP (Stage 7, 
Figure 3.3 – 3.5). Kvernevik WWTP, Ytre Sandviken WWTP, Holen WWTP, and Knappen WWTP 
were all 24-hour samples collected 07.10.2020. Flesland WWTP was 24-hour sample collected 
26.10.2020. Samples were kept cold and dark in methanol-washed Nalgene™ Wide-Mouth Lab Quality 
HDPE Bottles and frozen at -20 °C within 6 hours.  
 
3.1.2 Sludge samples 
Sludge samples (2-4 litres) (named station number + sludge) were taken from a pool containing an 
average of the past month’s produced sludge, and the samples are consequently representative of the 
average for the previous month. All sludge samples represent their stations’ sludge average during 
December 2020. Samples were kept cold and dark in methanol-washed Nalgene™ Wide-Mouth Lab 
Quality HDPE Bottles and frozen at -20 °C within 6 hours.  
 
3.1.3 Oasis HLB disk extraction and high-performance liquid chromatography (HPLC) 
Disk extraction, High Performance Liquid Chromatography (HLPC), and Electrospray ionization Mass 
spectrometry, was performed by Ivo Havranek, postdoctoral fellow, Faculty of Chemistry, 
Biotechnology and Food Science at Norwegian University of Life Sciences (NMBU).  
Disk extraction. Frozen samples were thawed at room temperature for about 24 hours, shaken thoroughly 
and a homogenous aliquot of 500 mL for each sample was taken and transferred to a clean 500 mL 
reagent glass. Oasis HLB columns (6 cc, 500 mg Sorbent per Cartridge, 60 µm) were conditioned with 
6 mL MeOH followed by 6 ml Milli-Q H2O. Internal standards (CBZ d10 – 7.5 ng per 500 mL sample, 
DEET d10, Metoprolol d7, and Octocrylene d15 on 50 ng per 500 mL sample) and water samples were 
added. Samples were run through HLB columns at 1-3 droplets/second using a vacuum manifold. 
Columns were washed with 6 mL 5% MeOH in Milli-Q water. The analytes were eluted with 5 mL 100 
% MeOH followed by 5 mL CH3CN into 12 mL glass tubes. The elutes were evaporated completely 
using nitrogen and 37 ± 3°C. 1 mL 20% MeOH in Milli-Q water was added to each dried sample and 
shaken at vortex for 10 seconds. Samples were then added to a microcentrifuge (Costar® Spin-X® 
Centrifuge Tube Filters, 0.22 µm Pore CA Membrane), and centrifuged at 12 000 rpm for 3 minutes, 
before being transferred to LC-MS glass with screw caps.   
High Performance Liquid chromatography (HPLC).  The targeted analysis was performed on an Agilent 
1200 series HPLC (Agilent Technologies, Waldbronn, Germany). A Zorbax Eclipse plus C18 RRHD 
(2.1 x 100 mm, 1.8 μm) (Agilent, Palo Alto, USA) with a respective Guard Cartridge (4 μm x 3.0 mm 
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ID) (Zorbax, Agilent, Palo Alto, USA) was used for chromatographic divisions, whilst the column 
temperature was kept at 25 ˚C. 10 µL was used as the injection volume. Separations were achieved 
applying a binary gradient with mobile phase containing of H2O with 0.1% formic acid (A) and pure 
CH3CN (B) with a mobile phase flow rate of 0.35 mL/min (v:v). The initial mobile phase proportion 
was 100 % (A). B was then linearly increased to 100 % over 8 minutes and kept for 7 minutes. Initial 
mobile phase conditions were restored over 1.0 minute and the column was equilibrating for 4 minutes 
resulting in an overall run time of 20 min. 
Electrospray ionization Mass spectrometry. An Agilent 6490 (Agilent Technologies, Santa Clara, CA, 
USA) triple quadrupole mass spectrometer with an Agilent Jet Stream electrospray ion source was used 
for the detection and quantitative analysis. The ions were monitored in positive and negative dynamic 
multiple reaction monitoring (dMRM). For instrument control, method validation and quantification, an 
Agilent MassHunter software (Version B.07.00 /Build 7.0.457.0, 2008) was used. 
3.2 The wastewater treatment plants 
Samples from WWTPs in this master thesis came from Ytre Sandviken WWTP, Kvernevik WWTP, 
Holen WWTP, Knappen WWTP and Flesland WWTP, all localized in the Bergen area, Western Norway 
(Figure 3.2). 
 
Figure 3.2 Overview of localisation of WWTPs studied. Kvernevik, Ytre Sandviken, Holen, Knappen, Flesland. 
Blue outlines the approximate collection area for Kvernevik WWTP, purple for Ytre Sandviken, brown for Holen, 
green for Knappen, and yellow for Flesland. Picture source kartverket.no, with modifications.  
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3.2.1 Activated sludge-based treatment plants 
Kvernevik WWTP is dimensioned for 56,000 population equivalents (pe, defined by the organic 
biodegradable load having a five-day biochemical oxygen demand (BOD5) of 60 g of oxygen/day 
(European Commission, n.d.)) and receives wastewater from Haukås, Flaktveit, Tertnes, Ervik and 
Morvik in Åsane. The treatment process involves a preliminary treatment with a grate, a sand and grease 
trap and a sedimentation pool based on activated sludge. This is the same system as in Flesland WWTP 
(Figure 3.3). Flesland WWTP is dimensioned for 152.000 pe and receives wastewater from the Nesttun 
area to Kokstad, Sandsli, Bergen Airport Flesland, and Blomsterdalen.  
 
Figure 3.3. Simplified illustration of wastewater treatment in Kvernevik and Flesland WWTPs 1) raw 
sewage enters the facility, 2) rotating screen (6 mm) traps waste and particles > 6 mm, 3) WW is lead to a sand 
and grease trap where air is added to facilitate rapid precipitation of sand, while fat floats towards the top and is 
removed, 4) the WW is directed to the biological treatment unit based on activated sludge, 5) air is injected through 
the bottom of a deep tank where the WW and activated sludge is present, 6) the mixture ends up in a large 
sedimentation basin, 7) treated water runs out at the surface of the basin and is released, 8) excess sludge is removed 
from the bottom of the basin and is added mechanical thickeners and centrifuged before sent to a biogas facility. 
Illustration based on information from Bergen municipality. 
 
3.2.2 MBBR and Actiflo-based treatment plants 
Ytre Sandviken WWTP has a capacity of 44,000 pe, and receives wastewater from the area surrounding 
Vågen, Skuteviken, Sandviken, Breiviken, Biskopshavn, and parts of Eidsvåg. The treatment process 
involves a preliminary treatment and a secondary treatment based on both a biological (Moving Bed 
Biofilm Reactor, MBBR) and a chemical step (Actiflo). This is the same treatment method as in Holen 
WWTP (Figure 3.4). Holen WWTP is dimensioned for 134,000 pe and receives wastewater from the 




Figure 3.4 Simplified illustration of wastewater treatment in Ytre Sandviken and Holen WWTPs 1) raw 
sewage enters the facility, 2) rotating screen (6 mm) traps waste and particles > 6 mm, 3) WW is lead to a sand 
and grease trap where air is added to facilitate rapid precipitation of sand, 4) sand is removed from the bottom of 
the pool and floating fat is removed at the top, 5) the WW is led to a MBBR (Moving Bed Biofilm Reactor) pool. 
Air is added and biofilm forms on large surface plastic beads. Due to a short retention time, the biofilm (bacteria) 
on these beads consumes only the suspended organic matter in the WW and grows till the biofilm drops off the 
beads and mixes in with the WW before being led to the chemical treatment (Actiflo), 6) Here, ferric chloride, 
sand and polymer is added. The WW is stirred to further facilitate flocculation of sand and sludge which sediments 
in the final section of the Actiflo treatment, 7) treated water runs out at the surface of the basin and is released 8) 
sludge is removed from the bottom of the basin and pumped to Actidyn (sludge thickening). Illustration based on 
information from Bergen municipality. Drawing of plastic bead from information leaflet about Ytre Sandviken 
WWTP, provided by Bergen municipality.   
 
3.2.3 Chemical treatment-based treatment plant 
Knappen WWTP is dimensioned for 63,000 pe, and receives wastewater from Minde, Fjøsanger, 
Kråkenes, Bønes, Fyllingsdalen, Hetlevik, Loddefjord and Bjørndalen The treatment process consists 
of a preliminary treatment and a secondary chemical treatment (Figure 3.5).  Knappen WWTP is the 




Figure 3.5 Simplified illustration of wastewater treatment in Knappen WWTP 1) raw sewage enters the 
facility, 2) rotating screen (3 mm) traps waste and particles > 3 mm, 3) WW is lead to a sand and grease trap where 
air is added to facilitate rapid precipitation of sand, while fat floats towards the top and is removed, 4) the WW is 
directed to a chemical treatment unit, 5) here, the amount of WW is measured in order to add correct amount of 
aluminium chloride and ferric chloride in the next step, 6) aluminium chloride and some ferric chloride is added 
which reacts with phosphate and creates aluminium phosphate particles, 7) the WW is sent through a flocculation 
chamber, 8) sedimentation pool where sludge and particles of aluminium phosphate sink towards the bottom, 9) 
treated water runs out of the surface of the basin and is released at 50 m depth in Grimstadfjorden, 9) sludge is 
removed from the bottom of the basin and is sent to sludge thickening. Illustration based on information from 
Bergen municipality. 
 
Table 3.2 Summary of treatment methods for the five chosen WWTPs 
WWTP Prelim.  Primary Secondary  Sludge  Recipient 



























40 m depth, 
Bergensfjorden 










150 m from land, 
50 m depth. 

































3.3 Plasmid preparation 
3.2.1 Escherichia coli (E. coli) transformation 
StrataClone SoloPack competent E. coli cells with Mix & Go from Agilent Technologies stored at -80 
°C were used. The cells were thawed on ice and added the plasmid pCMX Gal4 zfPXR-TL-LBD (midi 
10/5/17) with an original concentration of 2527 ng/L. 25 μL of a 1:100 dilution was then plated on a 
LB-agar plate containing ampicillin and incubated at 37 °C overnight. The same protocol was used for 
pCMX Gal4 Cod GR-LBD (mini 09/07/19) with an original concentration of 253.5 ng/uL. 
Following the transformation, a colony (positive transformant) was chosen, and transferred to 200 mL 
LB medium with 200 µL ampicillin in an Erlenmeyer flask. For (MH100)x4tk-luciferase, pCMV-β-
galactosidase, and the receptor plasmids for cod ARα-LBD, and cod ERα-LBD, a small amount of 
previously made glycerol stocks was used. The LB-medium containing ampicillin and positive 
transformant or glycerol stock was then incubated overnight (19 - 30 hours) in a Multitron standard 
shaking incubator from Infors HT at 37 °C and 250 rpm. 
3.2.2 Plasmid purification  
The plasmids must be purified before being used for transfection into COS-7 cells prior to exposure in 
the luciferase reporter gene assay. Medium-scale plasmid preparation (midi-prep) is a commonly used 
method to do this. 
Following the overnight incubation, the density of the cell culture was evaluated at 600 nm using a cell 
density meter (Ultraspec 10 Cell Density Meter, Amersham Biosciences). Optical density * cell volume 
(mL) = 200 ODV was calculated, and the bacteria were harvested by centrifugation (3500 g for 5 
minutes). The kit used was a NucleoBond® PC100 kit from Macherey-Nagel. The pellet was 
resuspended in RNase buffer to degrade any RNA present. After RNase treatment, SDS/alkaline lysis 
liberated the DNA content of the E. coli cells, and an acetate containing neutralization buffer was added 
to facilitate a supercoiled conformation of the plasmid DNA. Chromosomal DNA, proteins, and cell 
debris were precipitated. The supernatant containing the plasmid was applied to a silica-based column 
made to bind plasmid DNA. The column was washed afterwards with a buffer containing ethanol in 
order to remove any possible contamination. To elute the plasmid DNA from the column, an elution 
buffer was used (provided by the kit). The eluted plasmid DNA was precipitated by adding isopropanol 
followed by centrifugation and drying of the pellet using ethanol. Lastly, the final pellet was dissolved 
in 250 µL AE-buffer and plasmid DNA concentration and purity was measured using a Nanodrop 
instrument.  
3.2.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to investigate plasmid conformation. As nucleic acids are 
negatively charged, agarose gel electrophoresis can separate nucleic acids based on their size and charge. 
Hence, supercoiled plasmids will effectively be transported through the gel towards the positively 
charged side. A ladder (standard marker indicating size) was used to confirm correct plasmid 
conformation. Gels in this master thesis was produced according to Table 2.9 to a final concentration of 








3.4 Luciferase reporter gene assay (LRA) 
A luciferase reporter gene assay (LRA) was used to investigate if compounds in extracts from the 
wastewater samples could induce agonistic or antagonistic responses in various receptors from cod and 
zebrafish. The LRA involves three plasmids: a reporter-plasmid, a receptor-plasmid, and a control-
plasmid. All of them are transfected into COS-7 cells derived from African green monkey kidney tissue. 
The reporter-plasmid (MH(100)x4tk-luciferase) codes for luciferase. Luciferase is an oxidizing enzyme 
which produces bioluminescence (light) when the substrate luciferin is present (Figure 3.6). For the 
transcription of luciferase to be controlled, there is a Gal4-activation sequence (UAS) in its promoter-
region. The transcription only occurs when a receptor protein containing a Gal-4-DNA binding domain 
(DBD) goes through a conformational change, is activated, and binds to the UAS in the reporter-plasmid.  
The receptor-plasmid contains the receptor of interest. Fused to the ligand binding domain of this 
receptor is the abovementioned Gal-4-DBD. Upon exposure and activation, the ligand binds to the ligand 
binding domain (LBD). In turn, this leads to a conformational change in the Gal-4-DBD which is 
activated. In its activated form, Gal-4-DBD binds the UAS is the reporter-plasmid which leads to the 
expression and translation of luciferase as described above. Therefore, the binding of a ligand to the 
receptor works like a light-switch in the reporter plasmid. No (agonistic) binding = no light signal, 
(agonistic) binding = light signal. This light is measured at 560 nm and quantified after addition of the 
luciferin substrate. 
The third plasmid is the control-plasmid. This plasmid is the pCMV-β-gal and is used to normalize the 
measured light signal to number of cells as well as transfection efficiency. β-galactosidase hydrolyses 
ONPG to galactose and ONG which has a bright yellow colour that absorbs light at 420 nm. Due to this, 
β-gal activity can be measured as absorbance. 
 
Figure 3.6 Illustration of the principle behind the Gal4-DBD based luciferase reporter gene assay. Receptor 
plasmid contains the receptor gene and a Gal4-DBD. Upon ligand binding, this plasmid changes conformation, 
enabling the binding of Gal4 to the activation sequence (UAS) in the reporter plasmid. Downstream from this 
sequence in the reporter plasmid is the luciferase gene, which gets transcribed and translated. Luciferase is an 
enzyme which catalyses the reaction where luciferin is transformed to oxyluciferin, a process which results in 





3.4.1 Cultivation of COS-7 cells 
Aliquots of COS-7 cells (Table 2.4) in DMEM-10% FBS and 5% DMSO were stored in liquid nitrogen 
until thawed and added 10 mL DMEM-10% FBS. Subsequently, the cells were centrifugated for 5 
minutes at 250 g at rt. Medium was carefully removed and the pellet containing COS-7 cells were 
resuspended in 10 ml DMEM-10% FBS before plated in petri disks and incubated at 37 °C with 5 % 
CO2 until the cells reached a confluency of 60 – 80% and split. Splitting was conducted by removing 
old medium and washing the cells with 5 ml 1X PBS (pH 7.4) twice before adding 1.5 ml Trypsin-
EDTA (0.05% trypsin, 0.02 % EDTA) for the cells to detach from the surface of the plate. Excess trypsin 
was removed after 45 seconds, and the cells were incubated for approximately 5 minutes at 37 °C with 
5 % CO2. Afterwards, the cells were resuspended in DMEM-10% FBS and added to new plates in a 1:5, 
1:10 or 1:20 dilution with new medium.  
3.4.2 Seeding 
Cells were detached from plates following the same procedure as described under 3.3.1. and counted in 
a 1:1 solution with Erythrosine B using a Leica DM IL inverted microscope and a haemocytometer. 
Based on this, 100 uL containing approximately 5000 cells were seeded in each well in 96-well plates 
and incubated for 18 - 24 hours at 37 °C with 5 % CO2. 
3.4.3 Transfection 
Transfection is a method used to introduce foreign DNA into a eukaryotic cell. A transfection mixture 
(Table 3.4) consisting of Optimem, plasmid mix (Table 3.3), and transIT-LT1 reagent (Mirus Bio) was 
made and incubated at rt for 30 minutes. After 30 minutes, DMEM-10% FBS was added. The 96 well 
plates were taken out of the incubator and old medium removed. Each well was then added 101,4 µL of 
the transfection mixture with fresh DMEM before incubated at 37 °C with 5 % CO2 for 24 hours.  
Table 3.3 Plasmid mixture. Ratios of receptor plasmid 1:10 compared to reporter- and control plasmid. 
Plasmid Amount (ng) 
(MH100)x4 tk luc  47.62 
pCMV-β-Gal 47.62 
pCMX-GAL4-receptor plasmid 4.76 
Total 100.00 
 
Table 3.4 Transfection mixture. TransIT LT kit (Mirus Bio) based.  
Component µL per well 
Plasmid mixture (1µg/µL) 0.1 
Optimem 9.0 
TransIT LT1 0.2 
DMEM w/10% FBS 92.1 
Total 101.4 
 
3.4.4 Ligand exposure  
Old medium was removed from the 96 well plates, and test compounds (Table 3.5 - 3.6) dissolved in 
DMSO, or WW or sludge extracts (Table 3.7 – 3.9) in water with 20% MeOH, were serially diluted 
from well A - G in exposure medium. DMSO (for test compounds dissolved in DMSO) was added to 
the exposure medium (max 0.5 %) to give an equal concentration along the dilution gradient, as well as 
in the solvent control. Water with a 20% MeOH concentration was added according to the same principle 
for the extract sample testing. 
To assess the chosen receptors’ potential for activation by pharmaceuticals, some commonly used 
control-compounds were selected for testing in the luciferase reporter gene assays (LRAs). Moreover, a 
few frequently prescribed pharmaceuticals in Norway were tested as well. For testing of agonistic 
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properties, five compounds were selected (Table 3.5). Three compounds were used for antagonistic 
testing (Table 3.6).  
Table 3.5 Compounds used for in vitro agonistic testing on zebrafish PXR-TL, cod ARα, cod ERα and cod 
GR. All tested at seven concentrations. 
Plasmid Ligand Highest concentration [µM] DF 
Zebrafish PXR-TL Clotrimazole 3.0 5 
Cod ARα Testosterone 0.4 5 
Cod ERα EE2 0.4 5 
Cod GR Dexamethasone 100 5 
Prednisolone 100 6 
 
For testing of antagonistic properties, a background activation with either testosterone (ARα) or EE2 
(ERα) was used. The concentration of compound used as background activation was maintained 
constant along the exposure gradient, enabling the solvent control to be a control for background 
activation. Hence, any reduction in luciferase activity compared to solvent control could imply 
antagonistic properties of exposure compound or extract.  
 
Table 3.6 Compounds used for in vitro antagonistic testing on cod ARα and cod ERα. 
Plasmid Ligand Highest concentration [µM] Background activation DF 
Cod ARα Flutamide 20 0.005 μM testosterone 5 
Bicalutamide 100 5 
Cod ERα Tamoxifen 20 0.003 µM EE2 5 
 
Clotrimazole, Testosterone and EE2 were also analysed in parallel as an assay control.  
500 mL sample volumes of WW and sludge were extracted and reconstituted in 1 mL 20% MeOH, thus 
representing either 500 mL wastewater equivalents/ml (WWEQ/ml) or 500 mL sludge equivalents/ml 
(SEQ/mL). When exposing the transfected COS-7 cells, a smaller volume of the extracts was diluted in 
cell medium, with 30 mL WWEQ/mL (Table 3.7) and 30 mL SEQ/mL (Table 3.8) as the highest 
concentrations used. 
 
Table 3.7 Wastewater extracts used for in vitro agonistic testing of zebrafish PXR-TL, cod ARα and cod 
ERα, as well as antagonistic testing of cod ERα.  
Station Highest conc. 
mL WWEQ/mL 
No. triplicates DF 
PXR-
TL 




AR ER ER 
ant** 
Kvernevik-in 30 - 30 15 1 - 1 1 2 
Kvernevik-out 30 15 30* 15 3 3 2 2 2 
Ytre Sandviken-in 30 15 30* 15 3 3 2 2 2 
Ytre Sandviken-out 30 15 30* 15 3 3 2 2 2 
Holen-in 30 15 30* 15 3 3 2 2 2 
Holen-out 30 15 30* 15 3 3 2 2 2 
Knappen-in 30 15 30* 15 3 3 2 2 2 
Knappen-out 30 15 30 15 1 2 1 1 2 
Flesland-in 30 15 30* - 3 3 2 - 2 
Flesland-out 30 15 30* - 3 3 2 - 2 
* One triplicate with 30 mL, the other with 15 mL WWEQ/mL 






Table 3.8 Sludge sample extracts used for in vitro agonistic testing.  Identical concentrations, dilution and no. 
of triplicates for zebrafish PXR-TL, cod ARα, and cod ERα. 
Station Highest conc. 
mL WWEQ/mL 
No. triplicates DF 
PXR-TL AR ER ER ant* 
Kvernevik-sludge 15 15 15 15 2 2 
Ytre Sandviken-sludge 15 15 15 15 2 2 
Holen-sludge - - - - - - 
Knappen-sludge 15 15 15 15 2 2 
Flesland-sludge 15 15 15 15 2 2 
* 0.003 μM EE2 background activation  
 
3.4.5 Lysis and quantifying luciferase and β-galactosidase activation 
 3.4.5.1 Lysis 
Old medium containing exposure mixture was removed after 24 hours, and each of the wells were added 
125 µL lysis buffer with reagent solution (Table 3.11), which was incubated at rt for 30 minutes on a 
HS501 Digital shaker from IKA-Werke at 95 – 105 shaking frequency. Following this, 50 µL lysate was 
transferred to each well in a clear 96 well plate and the same volume of the lysate in a white 96 well 
plate. Clear plates were used for β-gal measurement (absorbance) whilst white plates were used for 
luciferase measurement (light).  
3.4.5.2 β-galactosidase activation 
To the clear plate, 100 µL β-galactosidase reagent (Table 3.11) was added to each well, and the plate 
was incubated for ∼ 20 minutes in rt until a bright yellow colour was obtained. The absorbance was 
measured at 420 nm in an EnSpire 2300 PerkinElmer plate reader.  
3.4.5.3 Luciferase activation 
To the white plate, 100 µL luciferase reagent (Table 3.11) was added to each well and the luminescence 
was measured immediately at 560 nm in an EnSpire 2300 PerkinElmer plate reader.  
Table 3.11 Lysis, β-galactosidase, and luciferase reagent 
Lysis reagent β-galactosidase reagent Luciferase reagent 
Components Conc. Components Conc. Components Conc. 
Lysis base buffer 
(Table 2.10) 
1 X β-gal. base buffer 
(Table 2.12) 
1 X Luc. Base buffer 
(Table 2.14) 
1 X 
EGTA 4 nM β-mercaptoethanol 52.9 mM DTT 5 mM 
MgCl2 8 mM ONPG 8.6 mM ATP 0.5 mM 
DTT 1 mM   CoA 0.5 mM 
PMSF 0.4 mM   D-luciferin* 0.5 mM 
    MilliQ H2O  
* Added right before measured. 
The data from the EnSpire 2300 plate reader (Perkin Elmer) was firstly treated in Microsoft Excel where 
the luciferase activity was normalized to the β-gal value of cells deriving from the same well. This was 
done to adjust for possible differences in transfection efficiency. Furthermore, the normalized luciferase-
activity was compared to the solvent control and calculated as fold change in luciferase activity. For 
further statistical analysis, GraphPad Prism 8 ® was used. 
 
3.5 Cell viability measurement  
A cell viability assay was performed to investigate whether any of the compounds or samples were 
cytotoxic to the exposed COS-7 cells. The cell viability assay follows the same steps as the LRA, except 
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the cells are not transfected on day 2. Instead, the old medium is removed, and new medium (101.4 µL) 
added. All cells were exposed to a max concentration of 30 mL WWEQ/mL with a dilution factor (DF) 
of 2, identical to the procedure used for the LRA. Triton X-100 was used as a positive control for cell 
death. 24 hours after exposure old medium was removed, the cells washed with 100 µl 1X PBS per well. 
In order to assess the cytotoxic properties of the extracts, 100 µl/well resazurin and 5-carboxyfluorescein 
diacetate acetoxymethyl ester (CFDA-AM) solutions was added to the cells. The 96 well plates were 
placed back into the incubator at 37 °C with 5% CO2 for 1 hour. Fluorescence was measured with 
EnSpire plate reader (PerkinElmer) at 530/590 nm for resazurin and 485/530 nm for CFDA-AM. As 
healthy cells transform resazurin (measuring metabolic activity) and CFDA-AM (measuring membrane 
integrity) to fluorescence signals, a significant reduction in fluorescence compared to non-exposed cells 


























4.1 Assessment of plasmids used in luciferase reporter gene assays. 
The integrities of plasmids used in the LRA were initially assessed with spectrophotometry and gel 
electrophoresis prior to the experiments. For spectrophotometry, absorbance at A260nm/280nm and 
A260nm/230nm were measured (Table 4.1) in order to indicate the purity of the DNA both in terms of protein- 
and chemical contamination.  
Table 4.1 Plasmid-DNA concentration and purity measured spectrophotometrically 
Plasmid Concentration (ng/µl) A260nm/280nm A260nm/230nm 
(MH100)x4tk-luciferase* 1606 1.94 2.38 
pCMV-β-galactosidase* 2959 1.90 2.33 
zebrafish PXR-TL*** 2285 1.91 2.34 
cod ARα** 1997 1.93 2.31 
cod Erα** 2387 1.93 2.34 
cod GR*** 2165 1.93 2.33 
* Mediprepped multiple times with slight variations in concentration 
** Cod ARα prepared by Siri Øfsthus Goksøyr (PhD student, Department of Biological Sciences, UiB). Cod ERα 
prepared by Rhîan Gaenor Jacobsen (chief engineer, Department of Biological Sciences, UiB) *** Zebrafish PXR-
TL and cod GR obtained from Roger Lille-Langøy  
 
Absorbance at A260 nm/280 nm of approximately 1.9 indicates no protein contamination. Values above 
2.0 for A260 nm/A230 nm indicates no chemical contamination. 
Gel electrophoresis (Method 3.2.3) shows the conformation of the plasmids. Based on the migration of 
the plasmids in the agarose gel, it appears that the majority of the plasmids have retained a supercoiled 
conformation (Figure 4.1). A supercoiled conformation is desired as it promotes an efficient transfection 
into COS-7 cells. 
 
Figure 4.1 Agarose gel electrophoresis of plasmids used in ligand activation experiments. Approximately 200 
ng purified plasmids were separated in a 1 % agarose 0.5X TBE gel for 45 minutes. The following plasmids were 
applied to lane 1 – 6 respectively; (MH100)x4tk-luciferase (1), pCMV-β-galactosidase (2), cod ARα (3), zebrafish 
PXR-TL (4), cod Erα (5) and cod GR (6). A 2-LOG ladder was applied to lane M as a reference marker. 
 
4.2 Cell viability 
The cytotoxicity of wastewater and sludge sample extracts to COS-7 cells were assessed using a cell 
viability assay measuring the metabolic activity and cell membrane integrity of the COS-7 cells. 
4.2.1 Cytotoxicity of wastewater samples 
The extract producing highest measured cytotoxicity was Kvernevik-in, where 30 mL wastewater 
equivalents (WWEQ) /mL resulted in more than a 90 % reduction in fluorescence in both resazurin 
(metabolic activity) and CFDA-AM (cell membrane integrity) (Figure 4.2). The extract was almost as 
effective as the positive control (Triton X-100) in producing a cytotoxic response. Generally, the 
metabolic activity was reduced with between 40 – 20% for the remaining in-samples, except Flesland-
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in, with a 10 % reduction compared to solvent control. The reduction in metabolic activity of the effluent 
samples were generally lower with approximately 10 % lower fluorescent signal compared to solvent 
control. Focusing on the conversion of resazurine, all stations had improved levels of metabolic activity 
for effluent samples compared to the influent samples.  
CFDA-AM, which indicate alterations in cell membrane integrity after exposure gave unresolved results 
for the influents. Fluorescence levels indicated increased membrane integrity at higher exposure 
concentrations, especially for Holen-in, and Knappen-in, where cell membrane integrity was measured 
to > 140 % compared to solvent control. This trend also appeared in Kvernevik-in at 15 mL WWEQ/mL, 
prior to significantly decreasing at 30 mL WWEQ/mL. The same remarkable results were not seen in 













Figure 4.2 Viability of COS-7 cells following 24h exposure to wastewater extracts. COS-7 cells were exposed to 
wastewater extracts in relevant ranges of concentration used for the LRAs. Solvent (milli-Q H2O with 20 % MeOH) 
in DMEM (equivalent to solvent concentration for the samples) was used as a negative control for cytotoxicity.  
Triton X-100 (1%) was used as a positive control for cytotoxicity, indicated by a black (rezasurin) and grey (CFDA-
AM) dotted line in each figure. Cytotoxic responses were defined as change in fluorescent signal compared to 
solvent control (defined as 100 %, indicated with red line). Black bars indicate metabolic activity measured by 


















4.2.2 Cytotoxicity of sludge samples 
The cell viability assay indicated a small reduction in fluorescence signals for resazurin with the highest 
observed effect in cells exposed to 30 ml SEQ/mL from Ytre Sandviken and Flesland, both at ~ 80 % 
relative fluorescence (Figure 4.3). There was also observed increased cell membrane integrity values, 
but only for Ytre Sandviken (115 %), and Knappen (155 %). The remaining stations has CFDA-AM 
results at between 80 – 90 %.  
 
 
Figure 4.3 Viability of COS-7 cells following 24h exposure to sludge extracts. COS-7 cells were exposed to 
wastewater extracts in relevant ranges of concentration used for the LRAs. Solvent (milli-Q H2O with 20 % 
MeOH) in DMEM (equivalent to solvent concentration for the samples) used as a negative control for cytotoxicity.  
Triton X-100 (1%) used as a positive control for cytotoxicity, indicated by a black (rezasurine) and grey (CFDA-
AM) dotted line in each figure. Cytotoxic responses were defined as change in fluorescent signal compared to 
solvent control (defined as 100 %, indicated with red line). Black bars indicate metabolic activity measured by 
resazurin.  Grey bars indicate plasma membrane integrity measured by CFDA-AM. Significance shown as * = p 
< 0,05 (TTEST). 
 
Table 4.2 Heatmap showing relative fluorescence in % compared to control. Resazurin results for two 
concentrations (15 and 30 mL WWEQ/ml, or mL SEQ/mL) shown for in-samples (a), out-samples (b), and sludge 
samples (s). Colours ranging from red indicating low metabolic activity, to green indicating metabolic activity at 












4.3 Luciferase reporter gene assay (LRA) testing of specific pharmaceuticals 
In order to assess the receptors’ potential for activation by pharmaceuticals, some commonly used 
control-compounds were selected for testing in the luciferase reporter gene assays (LRAs). Moreover, a 
few frequently prescribed pharmaceuticals in Norway were tested, including clotrimazole (for zf PXR-
TL), testosterone (cod ARα), EE2 (cod ERα), and dexamethasone and prednisolone (both cod GR). For 
antagonistic testing, flutamide and bicalutamide were used (cod ARα), as well as tamoxifen (cod ERα). 
All investigated agonists activated the receptors in a dose-response manner (Figure 4.4 – 4.5). Highest 
significant activation (Emax) and half maximal effective concentration (EC50) for all compounds tested 
are compiled in Table 4.3.  
 
Figure 4.4. Ligand activation of zf PXR-TL, cod ARα, and cod ERα by clotrimazole, testosterone, and EE2, 
respectively. Receptor plasmid, reporter plasmid ((MH100)x4tk-luciferase) and control plasmid (pCMV-β-
galactosidase) were transfected into COS-7 cells. The cells were exposed to seven concentrations of clotrimazole, 
testosterone, or EE2 for 24 hr. Activation of ligand is shown as relative fold change in luciferase activity in exposed 
cells compared to DMSO control. Each exposure was done in triplicates and individual experiments were 
performed three times. Dose-response curves were fitted by non-linear regression, with bars indicating SEM 
(GraphPad, PRISM v 7.0). 
 
 
     
Figure 4.5 Ligand activation of cod GR exposed to dexamethasone and prednisolone. Receptor plasmid, 
reporter plasmid ((MH100)x4tk-luciferase) and control plasmid (pCMV-β-galactosidase) were transfected into 
COS-7 cells. The cells were exposed to seven concentrations of dexamethasone (left) and prednisolone (right) for 
24 hr. Activation of ligand is shown as relative fold change in luciferase activity in exposed cells compared to 
DMSO control. Each exposure was done in triplicates and individual experiments were performed three times. 
Dose-response curve fitted by non-linear regression, with bars indicating SEM (GraphPad, PRISM v 7.0). 
 
As some pharmaceuticals act as antagonists, measurements of antagonistic effects were also performed. 
Compounds used were flutamide and bicalutamide (cod ARα), and tamoxifen (cod ERα), which have 
previously been shown to act as antagonists of these receptors (Table 2 and 4, Appendix). Lowest 
significant inhibition (Imax) and half maximal inhibitory concentration (IC50) for all compounds tested 







Figure 4.6. Antagonistic effects of flutamide (left) and bicalutamide (right) on cod ARα. Receptor plasmid, 
reporter plasmid ((MH100)x4tk-luciferase) and control plasmid (pCMV-β-galactosidase) were transfected into 
COS-7 cells. The cells were exposed to 7 concentrations of flutamide (left) and bicalutamide (right) for 24 hr as 
well as a fixed concentration of 0.005 μM testosterone (indicated as dotted line). Inhibition of ligand is shown as 
relative fold change in luciferase activity in exposed cells compared to DMSO control with testosterone. Each 
exposure was done in triplicates and individual experiments were performed three times. Dose-response curves 
were fitted by non-linear regression (flutamide) and best fit (bicalutamide), with bars indicating SEM (GraphPad, 
PRISM v 7.0) 
 
 
Figure 4.7 Antagonistic effects of tamoxifen on cod ERα. Receptor plasmid, reporter plasmid ((MH100)x4tk-
luciferase) and control plasmid (pCMV-β-galactosidase) were transfected into COS-7 cells. The cells were 
exposed to 7 concentrations of tamoxifen for 24 hr as well as a fixed concentration of 0.003 μM EE2 (indicated as 
dotted line). Inhibition of ligand is shown as relative fold change in luciferase activity in exposed cells compared 
to DMSO control with EE2. Each exposure was done in triplicates and individual experiments were performed 
three times. Dose-response curve was fitted by non-linear regression, with bars indicating SEM (GraphPad, 











Table 4.3 Highest significant activation (Emax), inhibition (Imax), EC50, and IC50 values for tested 
compounds. IC50 and EC50 value stated only when max activation/inhibition of receptor has been reached. Emax 
stated for agonists, Imax stated for antagonists.  








PXR-TL Clotrimazole Agonist 17.5 - <0.0001 0.209 - 
ARα Testosterone Agonist 14.0 - <0.0001 0.008 - 
ERα EE2 Agonist 27.1 - <0.0001 0.003 - 
GR Dexamethasone Agonist 6.3 - <0.001 - - 
GR Prednisolone Agonist 13.3 - <0.0001 4.965 - 
ARα* Flutamide Antagonist - 0.2 <0.0001 - 0.163 
ARα* Bicalutamide Antagonist/
biphasic 
- 0.2 <0.0001 - - 
ERα** Tamoxifen Antagonist - 0.3 0.0017 - 0.104 
* Background activation of 0.005 µM testosterone 




4.3 Receptor interactions by wastewater extracts  
To investigate whether compounds in wastewater samples from the five chosen treatment plants could 
induce agonistic effects on selected receptors, COS-7 cells were transfected and exposed to increasing 
concentrations of the different extracts (Method 3.2.3). Highest significant activation (Emax) and 
statistical significance for all wastewater extracts tested are summarized in Table 4.5.  
4.3.1 Agonistic effects of wastewater extracts 
For Kvernevik-in, the highest concentration was removed from the graph due to a significantly reduced 
cell viability (Table 4.2, cytotoxicity). 15 mL WWEQ produced a 1.9-fold activation for zebrafish PXR-
TL, but no activation was observed for cod ERα (Figure 4.9, left). Cod ARα was not included in the 
analyses of Kvernevik-in due to insufficient sample volume. For Kvernevik-out, 30 mL WWEQ induced 
6.3-fold increase in luciferase activity for zf PXR-TL, the highest activation in zf PXR-TL seen in all 
extracts. No effects were observed with cod ARα and cod ERα (Figure 4.9, right) in Kvernevik-out. 
 
Figure 4.9. Ligand activation of zf PXR-TL, cod ARα, and cod ERα exposed to WW sample from Kvernevik-
in and Kvernevik-out. Receptor plasmid, reporter plasmid ((MH100)x4tk-luciferase) and control plasmid (pCMV-
β-galactosidase) were transfected into COS-7 cells. The cells were exposed to 7 concentrations of ww-extracts for 
24 hr. Activation of ligand is shown as relative fold change in luciferase activity in exposed cells compared to 
solvent control. Each exposure was done in triplicates and individual experiments were performed three times for 
zfPXR-TL and ARα, and twice for cod ERα. Top concentration in Kvernevik-in was removed due to cytotoxicity. 
Cod ARα could not be included in the analyses of Kvernevik-in due to insufficient sample volume. Dose-response 





For Ytre Sandviken-in, both zf PXR-TL and cod ARα showed an increased activation at 30 ml 
WWEQ/mL and 15 ml WWEQ/mL exposure, respectively (Figure 4.10, left). No activation cod of ERα 
was observed. For Ytre Sandviken-out, zf PXR-TL and cod ARα showed an increase in luciferase 
activity of xx.x and xx.x at 30 ml WWEQ/ml and 15 ml WWEQ/ml respectively (Figure 4.10, right). 
No activation of cod ERα observed.  
 
Figure 4.10 Ligand activation of zf PXR-TL, cod ARα and cod ERα exposed to WW sample from Ytre 
Sandviken-in and Ytre Sandviken-out. Receptor plasmid, reporter plasmid ((MH100)x4tk-luciferase) and control 
plasmid (pCMV-β-galactosidase) were transfected into COS-7 cells. The cells were exposed to 7 concentrations 
of ww-extracts for 24 hr. Activation of ligand is shown as relative fold change in luciferase activity in exposed 
cells compared to solvent control. Each exposure was done in triplicates and individual experiments were 
performed three times for zfPXR-TL and ARα, and twice for cod ERα. Top exposure concentration was 30 mL 
WWEQ/mL for zf PXR-TL and ERα, and 15 mL WWEQ/mL for ARα. Dose-response curves were fitted by non-
linear regression, with bars indicating SEM (GraphPad, PRISM v 7.0). 
 
For Holen-in, the top concentration of 30 mL WWEQ/mL was removed due to cytotoxicity causing 
almost 40 % reduction in cell viability. Activation could be observed in PXR-TL at 7.5 and 15 mL 
WWEQ/mL. For cod ARα, a slight activation could be observed at ∼ 2 mL WWEQ/mL, before 
decreasing at increasing concentrations. Holen-out showed a higher activation of PXR-TL compared to 
the in-sample, although no concentrations here had to be removed due to cytotoxicity. A slight activation 
of cod ARα was observed. No significant activation of cod ERα was observed. 
 
 
Figure 4.11 Ligand activation of zf PXR-TL, cod ARα and cod ERα exposed to WW sample from Holen-in 
and Holen-out. Receptor plasmid, reporter plasmid ((MH100)x4tk-luciferase) and control plasmid (pCMV-β-
galactosidase) were transfected into COS-7 cells. The cells were exposed to 7 concentrations of WW-extracts for 
24 hr. Activation of ligand is shown as relative fold change in luciferase activity in exposed cells compared to 
solvent control. Each exposure was done in triplicates and individual experiments were performed three times for 
zfPXR-TL and ARα, and twice for cod ERα. Top exposure concentration was 30 mL WWEQ/mL for zf PXR-TL 
and ERα, and 15 mL WWEQ/mL for ARα. Top concentration in Holen-in was removed due to cytotoxicity. Dose-
response curves were fitted by non-linear regression, with bars indicating SEM (GraphPad, PRISM v 7.0). 




Knappen WWTP was the only treatment plant where the highest activation was observed in cod ARα, 
a trend revealed in both the in- and the out-sample. An activation of zf PXR-TL in the in-sample was 
observed, although with a larger response in the out sample. No significant activation of cod ERα was 
observed for neither in- nor the out-sample. 
 
Figure 4.12 Ligand activation of zf PXR-TL, cod ARα, and cod ERα exposed to WW sample from Knappen-
in and Knappen-out. Receptor plasmid, reporter plasmid ((MH100)x4tk-luciferase) and control plasmid (pCMV-
β-galactosidase) were transfected into COS-7 cells. The cells were exposed to 7 concentrations of WW-extracts 
for 24 hr. Activation of ligand is shown as relative fold change in luciferase activity in exposed cells compared to 
solvent control. Each exposure was done in triplicates and individual experiments were performed three times for 
zfPXR-TL and ARα, and twice for cod ERα. Top exposure concentration was 30 mL WWEQ/mL for zf PXR-TL 
and cod ERα, and 15 mL WWEQ/mL for cod ARα. Dose-response curves were fitted by non-linear regression, 
with bars indicating SEM (GraphPad, PRISM v 7.0) 
 
The final treatment plant that was examined was Flesland. Here, a slight activation in zf PXR-TL could 
be observed for both the in- and the out-sample. No activation was recorded in cod ARα and cod ERα 
for neither in- nor out-sample.  
 
Figure 4.13 Ligand activation of zf PXR-TL, cod ARα, and cod ERα exposed to WW sample from Flesland-
in and Flesland-out. Receptor plasmid, reporter plasmid ((MH100)x4tk-luciferase) and control plasmid (pCMV-
β-galactosidase) were transfected into COS-7 cells. The cells were exposed to 7 concentrations of ww-extracts for 
24 hr. Activation of ligand is shown as relative fold change in luciferase activity in exposed cells compared to 
solvent control. Each exposure was done in triplicates and individual experiments were performed three times for 
zfPXR-TL and ARα, and twice for cod ERα. Top exposure concentration was 30 mL WWEQ/mL for zf PXR-TL, 
and 15 mL WWEQ/mL for cod ERα and cod ARα. Dose-response curves were fitted by non-linear regression, 
with bars indicating SEM (GraphPad, PRISM v 7.0) 
 
4.3.2 Antagonistic effects of wastewater extracts 
As a multitude of pharmaceuticals act as antagonists on their target receptors, the antagonistic effects of 
the wastewater samples were also investigated. This was done with a constant background activation 









Figure 4.14 Ligand inhibition of cod ERα exposed to wastewater extracts. Receptor plasmid, reporter plasmid 
((MH100)x4tk-luciferase) and control plasmid (pCMV-β-galactosidase) were transfected into COS-7 cells. The 
cells were exposed to a fixed concentration of 0.003 μM EE2 and 7 increasing concentrations of WW-extracts for 
24 hr. Inhibition of EE2-mediated activation is shown as relative fold change in luciferase activity in exposed cells 
compared to solvent control. Each exposure was done in triplicates and individual experiments were performed 
two times. Top concentration 15 mL WWEQ/mL. Dose-response curves were fitted by non-linear regression, with 
bars indicating SEM (GraphPad, PRISM v 7.0). Extracts from Flesland were not included due to late arrival of 
samples. 
For all stations, except Knappen-out, a clear trend in reduction of luciferase activity was observed at 
increasing concentrations of wastewater extracts (Figure 4.14). Highest significant inhibition (Imax) and 
for all WW extracts tested are summarized in Table 4.5.  
Kvernevik-in Kvernevik-out 





4.3.3 Summary of ligand activation and inhibition of receptors exposed to wastewater extracts 
Table 4.5 Maximum response (Emax) fold change and half maximal effective concentration (EC50) for 
receptors exposed to wastewater extracts. Emax (best fit value) with concentration (mL WWEQ/mL) and p-value 
indicating statistical significance. 
* nt = not tested 
** No activation of ERα in any stations. See table 4.6 for antagonism. 
 
Table 4.6 Maximum response (Imax) for cod ERα exposed to fixed concentration of EE2 and wastewater 
extracts. Imax (best fit value) with concentration (mL WWEQ/mL) and p-value indicating statistical significance. 
*nt = not tested 
   
   
   
   
   
   
   
   
   
   
   
   
   













Receptor St. Maximum 
response (Emax) 
p-value EC50 
PXR-TL Kvernevik-in 1.8 0.5681 4.2 
Kvernevik-out 6.3 <0.0001 6.2 
Ytre Sandviken-in 2.17 0.2033 3.1 
Ytre Sandviken-out 3.73 <0.001 6.6 
Holen-in 2.01 0.0084 ~ 4.0 
Holen-out 2.32 0.002 9.4 
Knappen-in 1.58 <0.001 2.2 
Knappen-out 2.67 0.0122 5.4 
Flesland-in 1.62 <0.0001 ~ 5.5 
Flesland-out 1.43 0.2002 7.5 
ARα 
 
Kvernevik-in nt* nt* nt* 
Kvernevik-out 0.99 0.0137 1.0 
Ytre Sandviken-in 1.98 0.2062 1.7 
Ytre Sandviken-out 3.31 0.1998 5.1 
Holen-in 1.65 0.002 ~ 0.5 
Holen-out 1.80 0.0305 ~ 3.6 
Knappen-in 2.72 <0.001 0.7 
Knappen-out 3.83 0.1868 0.7 
Flesland-in 0.99 0.2783 1.5 
Flesland-out 0.98 0.2002 1.5 
ERα** 
   
   
   
   












Receptor St. % Reduction 










Kvernevik-in 38 % 0.62 0.4135 - 
Kvernevik-out 77 % 0.23 0.0013 ~0.06 
Ytre Sandviken-in 76 % 0.24 0.2046 0.31 
Ytre Sandviken-out 75 % 0.25 0.0331 1.23 
Holen-in 93 % 0.07 0.1075 4.97 
Holen-out 67 % 0.33 0.0001 15.00 
Knappen-in 87 % 0.13 0.0167 0.05 
Knappen-out 17 % 0.83 0.0280 0.58 
Flesland-in nt* - nt* - 
Flesland-out nt* - nt* - 
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Radar charts were made to summarize and visualize the WW extract activation and inhibition of the 
selected receptors (Figure 4.15). Kvernevik-out stands out as the WW sample causing the highest 
activation in PXR, whilst Knappen-in and Knappen-out stands out as the WW samples with the highest 
androgenic activity. 
 
Figure 4.15 Radar chart summarizing receptor activation of PXR and ARα exposed to wastewater 
extracts (left) and inhibition of ERα (right). Activation: shown as fold change in luciferase activity 
compared to solvent control (1). Inhibition: shown as percentage reduction compared to solvent control 
(0%). A 100% reduction indicates high inhibition. Flesland samples not tested for ERα antagonism due 


















4.4 Receptor interactions of sludge sample extracts  
COS7 cells were transfected with PXR, ARα or ERα to investigate whether compounds in sludge 
samples from four of the chosen treatment plants could induce agonistic effects. LRA was conducted 
following the same method as for wastewater samples. 
No significant activation was observed for any of the receptors exposed to the sludge sample extracts 
(Figure 4.16), although a trend towards decreased activation was observed. 
 
 
Figure 4.16 Luciferase reporter gene assay exposing zf PXR-TL, cod ARα, and cod ERα to sludge sample 
extracts from Kvernevik, Ytre Sandviken, Knappen and Flesland WWTPs. Receptor plasmid, reporter plasmid 
((MH100)x4tk-luciferase) and control plasmid (pCMV-β-galactosidase) were transfected into COS-7 cells. The 
cells were exposed to 7 concentrations of sludge sample-extracts for 24 hr. Activation of ligand is shown as relative 
fold change in luciferase activity in exposed cells compared to solvent control. Each exposure was done in 
triplicates and individual experiments were performed two times. Top concentration was 15 mL WWEQ/mL. 
Dose-response curves were fitted by non-linear regression, with bars indicating SEM (GraphPad, PRISM v 7.0) 
 
 
Figure 4.17 Summary of receptor activation and inhibition data by WW and sludge extracts. Shades from 
yellow to darker orange indicating increased Emax values, while green indicates no activation. Samples not tested 
marked as grey. 
 PXR  ARα  ERα  
ERα-
antagonism 
 -in -out -sludge  -in -out -sludge  -in -out -sludge  -in -out 
Kvernevik                          
Ytre Sandviken                          
Holen                          
Knappen                          
Flesland                          
* antagonism, orange indicates significant reduction in receptor activation, green indicates reduction but not 
statistically significant.  




4.5 Chemical analysis of wastewater extracts 
The targeted chemical analysis of the wastewater extracts detected acetaminophen, metoprolol, caffeine, 
prednisolone, carbamazepine, 5-h diclofenac, as well as the flame retardant TCPP and octocrylene (UV-
filter) in varying concentrations (Figure 4.18, and Table 4.7). Chemical analysis results for Kvernevik-
in and Knappen-in were inconclusive. The pharmaceutical detected at highest concentrations was 
acetaminophen, mainly detected at Ytre Sandviken-in, Holen-in and Knappen-out. Caffeine was the non-
pharmaceutical detected most frequently with up to 46,779 ng/L in Knappen -out. Both caffeine and 
acetaminophen (Figure 4.19) appear to decrease in concentration in effluents compared to influents. 
Interestingly, carbamazepine and TCPP appears to have increased concentration in effluents compared 
to influents.  
 
Figure 4.18 Levels of PPCPs in wastewater extracts. Concentrations of six compounds detected in targeted 
analysis. Flesland WWTP was not included due to late arrival of sample. Results for Kvernevik-in and Knappen-
in were inconclusive.  
 
 
Figure 4.19 Levels of caffeine and TCPP in wastewater extracts from four WWTPs. Flesland WWTP was not 


































































         
Kvernevik-out 55 - 390 18 197 563 1817 45 3086 
Ytre Sandviken-
in 
9311 239 42109 - 43 159 327 17 52206 
Ytre Sandviken-
out 
461 139 23800 - 52 247 1080 20 25798 
Holen-in 13604 209 32871 - 38 309 214 17 47261 
Holen-out 298 - 26853 - 72 309 815 25 28371 
Knappen-in** 
         
Knappen-out 15907 519 46779 168 191 169 1465 15 65213 
LOD 75 50 28 74 83 68 77 102  
LOQ 227 152 86 227 253 207 231 309  
* Instrumental carry-over for prednisolone, TCPP and octocrylene. See Appendix Table 9 and comment under 5.4 
General comments about sampling and chemical analysis.  





















5.1 Summary of the study 
This thesis aimed to investigate how a luciferase reporter gene assay using nuclear receptors from 
zebrafish and Atlantic cod can be utilized in detecting and monitoring the potency of pharmaceuticals 
released from WWTPs in Bergen, Norway. COS-7 cells transfected with either zebrafish PXR-TL, cod 
ARα, or cod ERα were exposed to extracts from wastewater or sludge for 24 hours, followed by 
measurement and quantification of luciferase activity reflecting receptor activation or inhibition. 
Cytotoxic properties of the extracts were measured using a cell viability assay. Additionally, targeted 
chemical analysis of the extracts for a selected set of compounds was conducted at NMBU (by postdoc 
Ivo Havranek). Differences in cytotoxicity, potency, and receptor interactions between untreated and 
treated samples obtained from the various WWTPs, have been identified and explored in this thesis.  
 
5.2 Cell toxicity caused by sample extracts 
A cell viability assay was used to assess if the extracts were toxic to the cells. Cytotoxicity-assays using 
various cell lines, have previously been proven useful in detecting extracts inducing cytotoxicity 
corresponding to a pollution gradient in sediments (Blanco et al., 2018), as well as detecting cytotoxicity 
in WW samples (Stalter, Magdeburg, Wagner, & Oehlmann, 2011; Xiao, Araujo, Sze, & Stuckey, 2015). 
The concentrations used in the cytotoxicity assay in this thesis correspond with concentrations used for 
the luciferase reporter gene assays (15 mL WWEQ/mL for ARα and ERα antagonism, and 30 mL 
WWEQ/mL as highest concentrations for PXR and ERα agonism). For the untreated wastewater 
samples, the average metabolic activity across all stations was reduced to 77 % compared to solvent 
control at 15 mL WWEQ/mL. At 30 mL WWEQ/mL this was decreased further to an average of 72 % 
for Ytre Sandviken-in, Holen-in, Knappen-in, and Flesland-in. The concentration corresponding to 30 
mL WWEQ/mL from Kvernevik-in clearly stood out with a dramatically decreased relative metabolic 
activity to only 6.2 % compared to solvent control. In comparison, the treated wastewater sample 
extracts had a relative metabolic activity of 85 % and 86 % at 15 mL WWEQ/mL and 30 mL 
WWEQ/mL, respectively, indicating a clear improvement. For the sludge samples, the average relative 
metabolic activity at 15 and 30 ml WWEQ/mL was 87 % and 85 %, respectively.  
Notably, the cytotoxicity of out-samples was lower than for the in-samples for all stations, indicating a 
removal of compounds producing cytotoxic responses. This difference in cytotoxicity in in- vs out-
samples may also contribute in some extent to the differences seen in activation of the receptors as 
reduced metabolic activity and/or reduced cell membrane integrity may influence the cells. 
The cytotoxicities produced by the influent samples are by themselves also interesting as several 
inhabitants in Norway are either not connected to wastewater treatment at all, or only to primary 
treatment plants. This means that there is a chance that cytotoxic effluents are being released into the 
environment continuously in several locations. An extensive review by Besse, Latour, & Garric (2012) 
found that a majority of anticancer drugs with cytotoxic properties detected in WW have only been 
tested in vitro, which makes it challenging to evaluate their environmental risk.  Elevated levels of 
disinfectants and antibiotics in WW have also previously been linked to cytotoxicity in human hepatoma 
HepG2 cells in vitro (Giuliani, Koller, Würgler, & Widmer, 1996; Žegura, Heath, Černoša, & Filipič, 
2009). However, it appears that linking the cytotoxicity detected in WW samples to environmental 
impacts requires further research. 
In addition to metabolic activity, the cell viability assay also included a measurement of cell membrane 
integrity. The CFDA-AM is an esterase substrate that can permeate the cell membrane, and once inside 
the cell the compound is hydrolysed by intracellular esterases, which results in fluorescent metabolites. 
This process requires a stable cell membrane. Multiple in-samples and a few sludge samples produced 
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cell membrane integrity values at > 120 % (Figure 4.2). An increased cell membrane integrity appears 
unlikely. One possible explanation could be that compounds present in the extracts reacts in such a way 
that it appears to increase the fluorescent signal alone. However, in that case one could expect a steady 
increase corresponding to increased amount of extract added for the samples. This contradiction is 
highlighted by the sudden decrease in CFDA-AM at 30 mL WWEQ/mL for Kvernevik-in, indicating 
that the increased values depend on a certain level of metabolic activity. The source of the increase in 
cell membrane integrity values, whether a result of methodology issues or compounds present in the 
samples, is yet to be discovered.  
 
5.3 Ligand exposure experiments  
To assess if contaminants in wastewater and sludge extracts could induce activation or inhibition of 
ligand activated receptors from zebrafish and Atlantic cod, in vitro reporter gene assays were used. 
Seven out of ten wastewater extracts activated the zebrafish PXR, although to various extent (Table 4.5). 
Extracts from both untreated and treated wastewater in Ytre Sandviken WWTP, Holen WWTP, and 
Knappen WWTP activated cod ARα, while none of the wastewater extracts induced activation of cod 
ERα. Notably, a general trend of increased activation of receptors by treated samples compared to 
untreated samples was observed. For cod ERα antagonism studies, most extracts appeared to have 
antagonistic properties. Sludge sample extracts did not induce activation of any of the receptors tested.  
 
5.3.1 Activation of zebrafish PXR 
The control compound clotrimazole activated the zebrafish PXR as expected, with a fold change in 
luciferase activity of 17.5 (t-test, p < 0.0001) compared to solvent control. All samples produced an Emax 
value above 1,4, although Kvernevik-in, Ytre Sandviken-in and Flesland-out were not statistically 
significant (t-test, p > 0.05).  
The stations activating zfPXR to the largest extent were Kvernevik-out (Emax = 6.3, p < 0.0001), Ytre 
Sandviken-out (Emax = 3.7, p <0.001), and Knappen-out (Emax = 2.6, p = 0.0122). As previously 
mentioned, it has been shown for several species, including zebrafish, that PXR has multiple agonists 
(Appendix, Table 6). This complicates the possibility to link receptor activation and chemical analysis, 
particularly as the chemical analysis in this thesis has been targeted towards relatively few compounds, 
meaning that several other yet unknown compounds may be present in the extracts. However, the 
stations with the highest activations of zebrafish PXR correspond to the top three highest concentrations 
of TCPP with concentrations between 1000 ng/L to 1800 ng/L. TCPP (Figure 5.1) is a flame retardant 
used in polyurethane foam for isolation (in freezer-rooms, cold-rooms, et cetera), as well as in furniture 
and various consumer products. The compound has been found to have agonistic properties in human 
PXR in vitro (Kojima et al., 2013), and has by the Danish EPA been added to the List of Undesirable 
Substances (LOUS) due to its possible mutagenic and reproductive effects (Larsen, Andersen, Lam & 
Slothuus, 2014). Screening of several Norwegian wastewater plants in 2011 identified TCPP as the 
dominating organophosphate flame retardant in wastewater effluents with a mean of 600 ng/L, and a 
maximum concentration detected of 1,160 ng/L  (Thomas et al. , 2011).  This compound has also been 
reported in creeks (68.3 – 5102 ng/L), offshore regions (<LOD – 329 ng/L), and in various sediment 
samples in Korea (Lee, Cho, Choi, & Moon, 2018). A screening program conducted by Akvaplan-niva 
also detected TCPP in most of the fish species sampled, as well as in 11 out of 14 seabird liver samples 
from Kongsfjorden and Leifdefjorden, Svalbard, Norway in 2008 (Evenset, Leknes, Christensen, 





Figure 5.1 Chemical structure of TCPP. Illustration from ChemSpider.  
Further research into possible activation of zebrafish PXR could contribute to a more definite answer of 
what compounds present in the extracts that are responsible for the activation. Nevertheless, the presence 
of relatively high levels of TCPP and the significant activation of zebrafish PXR indicates that 
compounds continuously released by WWTPs may pose a risk to marine environments.  
 
5.3.2 Activation of cod ARα 
The control compound testosterone activated the cod ARα with an Emax = 14.0 (t-test, p < 0,0001). Due 
to time constraints and limited sample volumes, cod ARα antagonism was not tested for the extracts, 
but only investigated for two compounds, i.e. the known antagonist flutamide and the compound 
bicalutamide. As flutamide, bicalutamide is an antiandrogen used in the treatment of hormone-sensitive 
prostate cancer (Berg, 2021). It is an androgen receptor antagonist by promoting inefficient recruitment 
of co-activators and thereby causing the transcription complex to be inactive (Kharlyngdoh, Pradhan, & 
Olsson, 2018). Flutamide decreased the testosterone-mediated ARα activation to 17 % compared to 
solvent control (t-test, p < 0.0001), demonstrating clear antagonistic properties. Bicalutamide also 
produced an antagonistic response at concentrations between 0.03 – 0.8 μM, decreasing the testosterone 
induced activation to 25 % compared to solvent control. At concentrations between 4 - 100 μM the 
antagonistic effects decreased, reaching 88 % activation at 100 μM. The reason for this biphasic response 
is unclear, but previous research has identified that the compound can acquire agonistic properties over 
time (Culig et al., 1999). The possibility of precipitation of bicalutamide at higher concentrations could 
also be investigated, although no precipitated material was observed with visual inspection during these 
experiments. 
The stations inducing the largest activation of cod ARα were Knappen-out, Ytre Sandviken-out, and 
Knappen-in (Table 4.5). However, many environmental contaminants known to bind AR are antagonists 
blocking the binding of natural agonists such as testosterone (Luccio-Camelo & Prins, 2011). One such 
compound is octocrylene (Figure 5.2). Octocrylene is not a pharmaceutical, but a broad spectrum 
ultraviolet absorbing compound added to sunscreens and makeup, as well as some plastic packaging. 
Under in vitro conditions, the compound has been associated with some anti-estrogenic, but primarily, 
anti-androgenic activities in human AR (Kunz & Fent, 2006a). It has previously been detected in 
WWTPs in Norway with a median concentration in effluents from Tomasjord, Tromsø, of 2 167 ng/L, 
VEAS, Oslo, with 258 ng/L and HIAS, Hamar, with 158 ng/L, indicating that mechanical treatment 
alone (as in Tomasjord) is not sufficient for octocrylene removal (Langford, Reid, Fjeld, Øxnevad, & 
Thomas, 2015). The same study also found that 80% of cod livers sampled from Oslofjord had detectable 
levels of this compound. Research from 2015 investigated six coastal locations in South Carolina, USA, 
and found an annual average concentration ranging from 37.6 to 497 ng/L (Bratkovics, Wirth, 
Sapozhnikova, Pennington, & Sanger, 2015). The levels of octocrylene detected by chemical analysis 
in this thesis varied between 20 and 45 ng/L (Table 4.7). The highest detected concentration was 45.15 
ng/L in Kvernevik-out, where a decrease in activation in the cod ARα agonistic assay could be observed 
(Emin = 0.74, p = 0.0137). However, antagonistic experiments are needed to confirm antagonism. 
Concentrations of 25 ng/L and 20 ng/L were detected for Holen-out and Ytre Sandviken-out respectively, 
where no significant activation in ARα was observed. Knappen-in, the station with the highest 
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significant activation (Emax = 2.7, p < 0.001) contained the lowest octocrylene levels measured (except 
for Kvernevik-in and Knappen-in where the chemical analysis was inconclusive), indicating a possible 
correlation between high levels of octocrylene and reduced activation of ARα. Compared to levels 
detected by Langford et al., 2015, the octocrylene levels in the samples collected in this thesis appear 
low. It should however be noted that a compound primarily used in sunscreen is likely to have strong 
seasonal variations. The samples collected and analysed in this thesis were taken in October, implying 
that the octocrylene usage might not be at its seasonal peak. Additionally, testing for antagonistic 
activities could contribute with knowledge on possible links between octocrylene and cod ARα activity.  
 
Figure 5.2 Chemical structure of octocrylene. Illustration from ChemSpider.  
The activation seen for Knappen-in indicates the presence of compounds with agonistic properties in 
the wastewater, but the targeted chemical analysis conducted here did not identify any compounds 
described as AR agonists. Previous research has described androgenic activity in environmental samples 
(Bellet et al., 2012). One of the most important sources of EDCs from WWTPs are natural estrogens 
and androgens excreted from humans (Liu, Kanjo, & Mizutani, 2009). This correlates with previous 
research identifying testosterone, dihydrotestosterone and epiandrosterone as partly responsible for 
androgenic activities detected in WW samples (Bellet et al., 2012). The androgen androstenedione has 
recently been observed in both wastewater influent and effluent, and has been confirmed as an androgen 
receptor agonist (Zwart et al., 2020).  
As highlighted by Bellet et al, 2012, natural androgens can explain some of the androgenic activity seen 
in wastewater, but not all. Sampling from three WWTPs in Norway in 2009 detected the flame retardant 
TBECH at concentrations between 5.4 (±0.5) (Drammen in) and 0,6 (±0.4) (Tromsø out.) ng/L (Nyholm, 
Grabic, Arp, Moskeland, & Andersson, 2013). Although at low concentrations, this compound has been 
identified as a potent human AR agonist, as well as inducing androgenic activities and causing negative 
effects on zebrafish physiology at higher concentrations (Pradhan et al., 2013). TBECH was not one of 
the compounds included in the targeted chemical analysis in this thesis. However, a possible connection 
between TBECH in wastewater and androgenic activity of environmental samples has previously been 
Suggested by Sørensen, 2020, who observed agonistic properties in sediment samples from 
Fisketorget/Vågen in Bergen in 2019, approximately 3 km from Ytre Sandviken WWTP (Goksøyr et 
al., 2021).  
5.3.3 Activation and inhibition of cod ERα 
The synthetic steroid EE2 was used as a positive control agonist, and activated cod ERα as expected, 
producing an Emax of 27.1 (t-test, p < 0.0001). Tamoxifen was used as a positive control for antagonism 
and decreased the EE2-mediated activation by 73% (t-test, p = 0.0017).   
None of the WW samples were able to activate cod ERα (Figure 4.9 – 4.13, Table 4.5). This corresponds 
well with the results of the targeted chemical analysis where no known strong estrogenic compounds 
were found. However,  estrogenic compounds such as estrone (E1), 17β-ethynylestradiol (EE2), and 
estriol (E3) (Liu et al., 2009; Välitalo et al., 2016) are known to be frequently detected in wastewaters 
worldwide, including in Norway (Thomas, 2007) . Research on eight WWTPs in Finland found that all 
wastewater effluents had estrogenic effects (Välitalo et al., 2016). However, a number of studies using 
the in vitro estrogen receptor reporter gene assay has detected antiestrogenic activities in environmental 
samples of wastewater (Conroy, Sáez, Quanrud, Ela, & Arnold, 2007; Ihara et al., 2014). Ihara et al 
(2014) compared the estrogenic activity to various compounds in wastewater and found that there seems 
to be a tendency for antiestrogenic compounds that can suppress the activity of natural estrogens, 
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ultimately indicating that luciferase assays reflect the net estrogenic balance of the samples. Such a 
possible masking-effect has also been reported in more recent research (Archer, Wolfaardt, van Wyk, 
& van Blerk, 2020). Altogether, the lack of receptor activation cannot be seen as an indication of no 
estrogenic compounds in the wastewater alone but should also be seen as an indication that there might 
be a net balance between estrogenic and antiestrogenic compounds. To assess if there was a net 
dominance towards antiestrogenic compounds, testing extracts with a background activation of ERα 
with EE2 was conducted.  
Possible antagonism caused by the extracts was measured by using the luciferase reporter gene assay 
with cod ERα and a fixed background activation with EE2. Kvernevik-out, Ytre Sandviken-out, Holen-
out and Kvernevik-in were identified as stations causing statistically significant reductions in luciferase 
activity compared to solvent control. Compounds detected with antiestrogenic properties in the chemical 
analysis are octocrylene (also an antiandrogen, mentioned in 5.3.2) and diclofenac (Ezechiáš, 
Janochová, Filipová, Křesinová, & Cajthaml, 2016). Diclofenac (sold under names such as Voltaren and 
Voltarol in Norway) is an analgetic and anti-inflammatory drug which works by being a non-selective 
inhibitor of COX1 and COX2-enzymes (Reiter, 2017). It may also inhibit the PPARγ receptor (Gan, 
2010). 5-H diclofenac is one of three metabolites of diclofenac in humans and its production is catalysed 
by CYP2C and CYP3A4 enzymes. Research suggests that diclofenac (and ibuprofen, a widely used non-
steroidal anti-inflammatory drug) act as inhibitors of the estrogen receptor pathway in vitro (Ezechiáš 
et al., 2016). More research is needed to identify the definite cause of cod ERα inhibition produced by 
these extracts, especially in terms of metabolite binding potencies as well as in terms of differences 
between the treatment methods. The detection of 5-H diclofenac is nevertheless interesting.  
The concentrations at which 5-H diclofenac was detected varied between 170 (Knappen-out) and 560 
ng/L (Kvernevik-out), which correspond to levels previously measured in Norway. 5-H diclofenac has 
formerly been detected at 551 ng/L in Tromsø and 675 ng/L in Oslo (Langford & Thomas, 2011). In 
seawater specifically, diclofenac concentrations have been reported at 1-4 ng/L (Longyearbyen, 
Norway) (Kallenborn, Brorström-Lundén, Reiersen, & Wilson, 2018) and up to 241 ng/L on the 
Northwestern Portuguese coast (Lolić et al., 2015). An extensive review on detected diclofenac 
concentrations in water, sediments and organisms from 2018 identified a scarcity of research on the 
occurrence and possible effects of diclofenac in the marine environment (Bonnefille, Gomez, Courant, 
Escande, & Fenet, 2018). Other commonly detected anti-estrogens in wastewater includes tamoxifen, 
with levels up to 180 ng/L (Negreira, de Alda, & Barceló, 2014). Research using both in vitro and in 
silico modelling identified additionally the anti estrogens raloxifene and bazedoxifene acetate as 
pharmaceuticals in wastewater with potential to reach fish tissue at relevant concentrations (Pinto, 
Bloom, & Laurenson, 2019). 
 
5.3.4 Activation of cod GR 
Dexamethasone is a known human GR agonist and was used to test if the compound could activate cod 
GR as well. At 100 μM, an Emax of 6.3 was observed, demonstrating the compound’s ability to act as a 
cod GR agonist. Similarly, prednisolone was also tested and produced an Emax of 13.3 at 100 μM. Cod 
GR was not used in testing of wastewater and sludge extracts in this thesis due to time constraints and 
limited extract volumes. The demonstrated ability of cod GR to bind commonly used pharmaceuticals 
does nevertheless propose that this receptor might be useful and relevant in future environmental 
research and monitoring. GR may be particularly interesting in testing of sludge samples, as recent 
research has detected glucocorticoid activity in all sludge samples from Australian WWTPs (Papa, 




5.3.5 Compounds detected by chemical analysis 
In addition to the abovementioned compounds, acetaminophen, metoprolol, prednisolone, 
carbamazepine, and caffeine were detected by the targeted chemical analysis of the WWTP samples.  
Acetaminophen (also known as paracetamol) is an analgetic (pain relieving) and antipyretic (fever-
reducing) drug. Its mode of action is not completely understood, but it works partly by inhibiting the 
enzyme COX-2 (cyclooxygenase – 2) and stimulates pain relief by increasing the levels of serotonin in 
the central nervous system (Spiering, Lisa, Dietrichs, 2020). Although debated, its primary site of action 
is believed to be the activation of cannabinoid receptors via one of its metabolites (Klinger-Gratz et al., 
2018). The compound has been detected in concentrations between 12 – 9,600 ng/L (lagoon, Spain), 
and between <20 and 930 ng/L in recipient waters in Greenland, Iceland, and the Faroe Islands (Huber 
et al., 2013; Moreno-González et al., 2014). Influent samples from VEAS WWTP, Oslo, contained 
paracetamol at the highest maximal concentration of 43,000 ng/L and a median concentration of approx. 
3 500 ng/L, with a median in effluent samples of 31 ng/L (Thomas, 2007). The levels detected in samples 
from the five WWTPs in Bergen ranged from 55 ng/L (Kvernevik-out) to 16,000 ng/L (Knappen-out). 
The general trend showed decreasing levels in out-samples compared to in-samples, although in-samples 
from Kvernevik and Knappen were inconclusive.  
Metoprolol (Selo-Zok®) is one of multiple pharmaceuticals that block β-adrenergic receptors, and it 
works directly on the heart by specifically blocking the β1-adrenergic receptors. This results in a reduced 
heartbeat frequency and hence lowers the blood pressure (Alrawaf, 2019). The levels detected in samples 
from the five WWTPs in Bergen ranged from not detected to 520 ng/L in Knappen-out. These levels are 
comparable to what has previously been detected elsewhere. Metoprolol was identified in all samples, 
ranging from 51 to 810 ng/L in WW effluents investigated in Greenland Iceland and the Faroe Islands 
in 2013 (Huber et al., 2013). In Mediterranean sewage water the compound has been detected at about 
200 ng/L (Desbiolles, Malleret, Tiliacos, Wong-Wah-Chung, & Laffont-Schwob, 2018).  
Prednisolone is a metabolite of the synthetic glucocorticoid prednisone. It is used in treatment of 
rheumatic diseases, inflammatory bowel disease, severe asthma, and chronic obstructive pulmonary 
disease (COPD), and as a part of a cancer treatment (Solsvik, 2019). Prednisolone is highly effective at 
treating inflammation through its binding to the glucocorticoid receptor. The compound has previously 
been detected in wastewater influents in concentrations between 315 – 1918 ng/L in The Netherlands 
(Schriks et al., 2010). The levels detected in samples from the five WWTPs in Bergen were for all 
stations below limit of detection except in Kvernevik-out with 18.08 ng/L and Knappen-out with 168 
ng/L.  
Carbamazepine (Tegretol/Trimonil) is a sodium channel blocker used in treatment of epilepsy, specific 
types of nerve pain, in treatment of bipolar disorders, and alcoholism. It is also a potent inhibitor of the 
muscarinic and nicotinic acetylcholine receptors, N-methyl-d-aspartate (NMDA) receptors, and 
adenosine receptors in the central nervous system (Lo, 2014). Carbamazepine was detected in 
concentrations between 37 ng/L (Holen-in) to 200 ng/L (Kvernevik-out). Previous research has detected 
carbamazepine at a mean concentration of 393 ng/L and 294 ng/L in treated wastewater samples from 
VEAS, Oslo, and Breivika, Tromsø, respectively (Langford & Thomas, 2011). Additionally, the 
compound was identified in 37 out of 43 samples in coastal and offshore seawater sampled in the Baltic 
Sea with a median concentration of 2.6 ng/L (Björlenius et al., 2018). The same authors investigated 
WWTPs in Denmark, Finland, France, Germany, Great Britain, Japan, Poland, Spain, and Sweden, and 
found that the removal efficiency of carbamazepine varied from 31 - 41 % with more than half of the 
WWTPs having higher levels of carbamazepine after treatment compared to before treatment. One 
explanation suggested by the authors of the article is the deconjugation of the compound that might 
happen through the treatment process (Björlenius et al., 2018). As described in the introduction (1.1.1, 
Pharmaceuticals), many pharmaceuticals are excreted from our bodies in a conjugated form. Throughout 
the treatment process, deconjugation may occur due to the presence of bacteria such as E. coli, which 
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exhibits enzymatic activity, and thereby an "increase” the concentrations of the original compound in 
the effluents can be observed  (Gomes, Scrimshaw, & Lester, 2009; Verlicchi, Al Aukidy, & Zambello, 
2012). This correlates well with the findings in this master thesis where an increase in carbamazepine 
was observed in both Ytre Sandviken WWTP (+19.4 %) and Holen WWTP (+90.8%). Carbamazepine 
is also known for its long half-life in the environment with 82 +/- 11 days (Sanderson et al., 2004).  
Caffeine is a compound naturally present in coffee (about 150 mg/cup) and tea (about 50 mg) and is 
added to various energy drinks and supplements. Caffeine is a stimulant which increases brain activity 
and decreases drowsiness (Bjørneboe & Johansen, 2021). These effects come as a result of various 
biochemical processes, but mainly as a result of the caffeine being an antagonist to adenosine receptors 
(A1, A2A, A2B, and A3), which blocks the binding of adenosine in the nervous system (“Kaffein,” 
2018). Some coffee and tea enter the wastewater system simply by being discharged. In addition, about 
5 % of ingested caffeine is excreted without being metabolized (Magkos & Kavouras, 2005). The levels 
detected in samples from the five WWTPs in Bergen ranged from 390 ng/L (Kvernevik-out) to approx. 
47.000 ng/L (Knappen-out). In comparison to previously detected levels in wastewater (e.g. 2.000-
293.000 ng/L in Tromsø (Weigel et al., 2004)), the concentrations are as expected. Levels of caffeine 
detected in the environment in Europe has been found in concentrations up to 17.400 ng/L in Romania 
(Gheorghe, Petre, Lucaciu, Stoica, & Nita-Lazar, 2016), 857 ng/L in Spain (Dafouz et al., 2018), and 
ranging between 7 – 87 ng/L in seawater in Tromsø, Norway (Weigel et al., 2004).  
 
5.3.6 Sludge samples 
None of the sludge samples extracts activated PXR, ARα or ERα. A decrease in luciferase activity was 
observed for many for the receptors at increased concentrations of the extracts, indicating that 
assessment of antagonism could provide useful information. This was planned, but not conducted due 
to late arrival of extracts to our laboratory. Chemical analysis of sludge samples was also not performed 
due to limited time.  
Prediction of distribution of compounds in different environmental compartments is commonly based 
on  Log Kow values, indicating the relationship between the lipophilicity and hydrophilicity of a 
substance (Hendriks, van der Linde, Cornelissen, & Sijm, 2001). However, some research has found 
that models based on Kow for environmental fate of pharmaceuticals might not be suitable for prediction 
of levels in soils and sludge (Lindberg, Fick, & Tysklind, 2010; Tolls, 2001) emphasizing the need for 
chemical analysis. 
Compounds frequently detected in European sludge samples do however include compounds such as 
diclofenac (1.3 – 429.1 ng/g, detected in 81 % of trials), and ibuprofen (0.2 – 108.2 ng/g, detected in 
42.4 % of trials) (Fijalkowski, Rorat, Grobelak, & Kacprzak, 2017). Diclofenac, as previously described, 
is a known ERα antagonist, and ibuprofen act as an agonist on human PPARγ (Cosgrove et al., 2021). 
Recent research has also detected glucocorticoid activity in all sludge samples from Australian WWTPs 
(Papa et al., 2022), emphasizing that the glucocorticoid receptor might be an interesting receptor for 
investigation of biological activity in sewage sludge samples. Additionally, antimycotics such as the 
PXR agonist clotrimazole (Svecova et al., 2008) and the PXR antagonist ketoconazole (H. Huang et al., 
2007) has been detected in all sludge samples investigated and measured at concentrations between 60 
and 1800 μg/kg dry weight in six Swedish WWTPs (Lindberg et al., 2010). The same study concludes 
that the major route of antimycotics into the environment is through sludge used as fertilizer or landfill 
material.  
The sludge from the investigated WWTPs in Bergen is used in biogas production, and the result is biogas 
digestates that are commonly used as fertilizers and soil for green areas in connection with infrastructure 
development (Statens vegvesen, 2019). Research on biogas digestates from several Norwegian 
production plants has found that the processes within biogas production facilities does not eliminate the 
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compounds investigated (Ali et al., 2019). Octocrylene and TCPP was even found at levels exceeding 
the upper limit of quantification threshold (>600 ng/g wet weight, and > 500 ng/g wet weight, 
respectively)(Ali et al., 2019).  
Ultimately, this emphasises that sludge and digestate samples must be included when assessing the 
possible environmental risk of pharmaceuticals derived from wastewater, since what appears as a 
removal when comparing in-and out-samples might just be a channelling of compounds from WW to 
sludge. 
 
5.3.7 Summary of luciferase reporter assay and targeted chemical analysis findings  
By summarizing the maximal activations (Emax) and inhibitions (Imax) observed by the different 
wastewater extracts, the environmental quality of the various influents and effluents can be assessed. 
The luciferase assay data partly correspond to the chemical analysis where Kvernevik-out showed the 
highest concentrations of several compounds (Table 4.7, Figure 4.19). Solely evaluating the removal 
efficiencies between the WWTPs in terms of chemicals detected, Knappen WWTP stands out. Although 
chemical results for Knappen-in were inconclusive, the results from Knappen-out identifies it as the 
only effluent samples where significant amounts of acetaminophen, metoprolol and caffeine are 
detected. Knappen-out also had the highest total concentration of compounds (Table 4.7) Knappen 
WWTP is the only treatment plant with solely chemical treatment, indicating that biological treatment 
might be more effective in removal of certain compounds than chemical treatment alone. This is 
supported by reviews summarizing knowledge on various treatment methods reporting that EDCs and 
PPCPs to a large extent gets removed through activated sludge and in membrane bioreactors 
(MBRs)(Ahmed et al., 2017; Hamid & Eskicioglu, 2012).  
Initially, multiple samples from the WWTPs were collected, as several samples are needed to distinguish 
brief and random variations to differences caused by the treatment methods. Although all samples were 
based on a 24-hour sampling pool, this suggests that differences seen between the wastewater treatment 
plants could be random and limited for the one sampling day. The in- and out-samples are not taken 
with the retention time within the treatment plants in mind, although the composition is believed to be 
relatively representative due to the large masses of water within the plants. Unfortunately, limited time 
has resulted in only one sampling from each WWTP being analysed in this thesis. For details on what 
this implies, see 5.4. General comments about sampling and chemical analysis.  
 
5.3.8 Significance of the findings in an Adverse Outcome Pathway perspective 
The interaction between a ligand and a receptor is a key event in the adverse outcome pathway (AOP), 
as described in the introduction. The findings of this thesis illustrate the ability of compounds in both 
untreated and treated wastewater to bind to nuclear receptors which have important roles in xenobiotic 
metabolism, reproduction, and development.  
PXR is the main transcriptional regulator of CYP3A, which catalyses the first step in the detoxification 
of xenobiotics (Moore et al., 2002). Induction of CYP3A has also been identified following exposure of 
clotrimazole to zebrafish PXR, suggesting resemblances in response pathways in zebrafish and 
mammals (Bresolin, De Freitas Rebelo, & Dias Bainy, 2005). Detoxification of xenobiotics is needed 
and highly useful for the organism (as described in Introduction 1.1.1) although activation of PXR may 
cause unwanted side effects as activation of PXR results in upregulation of e.g. transferases, increased 
biliary excretion of the thyroid hormones T3 and T4, which alters the thyroid hormone system critical 
in normal development (Brucker-Davis, 1998; D., M., C., & Thomas, 2009; Schuetz, Brimer, & Schuetz, 
1998). Teleost thyroid follicles has been found to produce the same thyroid hormones (T3 and T4) as 
other vertebrate species, including humans (Shkil, Siomava, Voronezhskaya, & Diogo, 2019), indicating 
an environmental significance. Recent research has also identified activation of PXR as the molecular 
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initiating event of flame retardant-induced dose-dependent lipid accumulation and mitochondrial 
dysfunction in human liver cells in vitro (Negi, Bajard, Kohoutek, & Blaha, 2021). These factors do 
altogether suggest that activation of PXR may lead to both cellular and organ responses, although more 
research is needed to identify if the compounds and activation seen in this thesis are substantial enough 
to cause organ or organism responses in the environment. 
The AR has, as mentioned in the introduction several important roles such as in development and 
maintenance of the reproductive system (Davey & Grossmann, 2016). Exposed fish to ng/L 
concentrations of the androgen 17β-trenbolone has been shown to cause changes in endocrine function 
in both short term and long term exposures, including skewed sex ratios and reduced fertility (Ankley 
et al., 2018). River waters with very high androgen levels (due to pig farm wastewater input) have been 
found to cause adverse effects such as masculinization and inhibited vitellogenin levels in female 
mosquitofish (G.-Y. Huang et al., 2019), and the androgen trenbolone has been identified as a cause of 
irreversible masculinization of zebrafish at environmentally relevant concentrations (Morthorst, 
Holbech, & Bjerregaard, 2010). The Atlantic cod androgen receptor activation produced by WW from 
some of the stations in this thesis suggests that further research is needed to establish if any potential 
effects on fertility and development could be caused by wastewater on this species specifically. 
Vitellogenin has for long been a standard biomarker for estrogenic activity in oviparous vertebrates, as 
the protein should be detected at negligible levels in males and immature females (Arukwe & Goksøyr, 
2003; Oberdörster & Cheek, 2001; Sumpter & Jobling, 1995) and any increased vitellogenin production 
indicates exposure to estrogenic compounds. No estrogen receptor activation was detected in the 
samples from the five WWTPs in this thesis, although multiple extracts showed antagonistic properties. 
One of the compounds with suggested antiestrogenic properties is octocrylene. Exposure of zebrafish to 
octocrylene revealed accumulation of the compound, and a subsequent microarray analysis identified 
changes in genes involved in developmental processes, organ development, fat cell differentiation, and 
metabolism (Blüthgen, Meili, Chew, Odermatt, & Fent, 2014). A search of relevant literature for 
octocrylene and other potential estrogen receptor inhibitors for Atlantic cod estrogen receptor yielded 
no related articles. Further research linking estrogen receptor inhibition in Atlantic cod to cellular and 
organ responses could be highly useful. 
Although several of the wastewater effluent samples induced significant changes in some receptors, one 
should bear in mind that the likelihood of the WW extract compounds reaching its target site within an 
organism in these concentrations is low. Several abiotic factors influence the effluents when released, 
such as dilution (Weigel et al., 2004), photodegradation (Andreozzi, Raffaele, & Nicklas, 2003; Buser, 
Poiger, & Müller, 1998; Fent, Weston, & Caminada, 2006), and temperature (Vieno, Tuhkanen, & 
Kronberg, 2005). This thesis illustrates how a mixture of compounds may interact with receptors at a 
molecular level, illustrating the possibility for a molecular initiating event, given that an organism is 
exposed, the compound is absorbed and distributed to the cite of interaction.  
Combined with the elevated cytotoxicity for several of the samples, these findings highlight the 
importance of authorities evaluating biological potencies, as well chemical composition, when assessing 
the environmental impact of released WW. The information provided in this thesis could also contribute 
to knowledge useful when assessing the removal efficiencies of different WWTPs in Bergen.  
 
5.3.9 Comments to the luciferase reporter gene assay 
The luciferase reporter gene assay is a commonly used method to investigate ligand activation of nuclear 
receptors in vitro. A Gal4/UAS based system was used in this master thesis, which enables the 
investigation of interactions between the ligand and nuclear receptor without PXR being dependent on 
the presence of RXR.  
55 
 
The cell line chosen for this thesis (COS-7), was selected based on its properties as robust and easy to 
work with. The endogenous expression of the receptors studied are low as COS-7 cells are cells derived 
from the kidneys, generally regarded as a non-steroidogenic organ. This implies that the receptor 
activation seen in the experiments would be minimally influenced by the cell line itself. However, 
different cell lines may have various expression of cofactors available necessary to initiate transcription, 
and some research has disputed the non-steroidogenicity of the COS-7 cells (Nozaki et al., 2018). This 
implies that a different response of the zebrafish and Atlantic cod receptors in their natural cells cannot 
be ruled out. 
Comments made about anti-estrogenic compounds masking for estrogenic properties of the wastewater 
may be relevant for all receptors, implying that the reporter gene assay results should be read as a net 
receptor activation. What may appear as a “non-significant response” may in fact be a balance between 
agonist and antagonists in the wastewater sample. 
 
5.4 General comments about sampling and chemical analysis 
The samples analysed are from one day only and reflects the biological activity and chemical properties 
of a limited time period. A significant variation in compounds detected over time has been demonstrated 
by previous research, exemplified by a transient increase in discovered anabolic steroids and weight loss 
products in WW following a sports event (Causanilles et al., 2018). Likewise, concentrations of drugs 
such as cocaine and MDMA has been found to vary significantly between various locations as well as 
throughout a week (Löve et al., 2018). Compounds used in sunscreens and insect repellents are also 
more likely to be present in the summer months compared to the autumn (when the samples in this thesis 
was collected) (Ekpeghere, Kim,  Kim & Oh, 2016; Knepper, 2004) These factors as well as differences 
in retention-time within treatment plants, weather conditions and shifts in demographics, highlights the 
importance of multiple samples taken throughout a year. Flesland samples can also only to a limited 
extent be compared to the other samples as this was taken two weeks later and on a different weekday 
than the others.  
The stability of certain analytes in WW has been shown to be influenced by storage temperature, and 
certain compounds have been found to undergo significant degradation even at low temperatures. At -
20°C, the compound clomiphene (antiestrogen) has been observed to have a 25 % decrease after 3 days 
illustrating the importance of immediate freezing and quick analysis of wastewater samples  (Causanilles 
et al., 2018). For the Flesland samples and sludge samples this may be of particular relevance as they 
were sampled at a later point, and were stored for approximately 5 months at -20 °C. 
Multiple pharmaceuticals are also easily degradable by light. All samples have been treated as light 
sensitive and have been shielded from light as far as possible, but some light degradation of the 
compounds cannot be excluded.   
The HLB disk method used (at NMBU) in this thesis is frequently used as a method to extract 
pharmaceuticals from water and wastewater samples (Česen & Heath, 2017; Neale, O’Brien, et al., 
2020; Yuan, Jiang, Xia, Zhang, & Zheng, 2013). Variations in recovery between various compounds 
may however influence the results. Previous research on recovery of various compounds (e.g. UV filters) 
revealed recoveries varying between 79% and 118 % (Ekpeghere et al., 2016)  Recoveries may also 
influence the LRA and cytotoxicity assays, as several compounds in the wastewater might not be 
efficiently extracted by the extraction method in the same extent as others. This could influence the final 
concentrations in the extracts used for exposure experiments. 
Shortly before the deadline for handing in the thesis, I was made aware that instrumental carry-over and 
contamination had occurred for several compounds. Had this been noticed earlier, the average blank 
sample contamination could have been subtracted from the reported levels in the results section making 
the reported concentrations more accurate. A table (Table 9) has been added in appendix with the 
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average contamination in blank samples. The specific compound concentrations reported in this thesis 
should therefore be interpreted with caution. Instrumental carry-over does however not influence the 
levels of compounds in the extracts used for LRA and cytotoxicity assays.  
 
5.5 Conclusion  
By extracting, analysing, and exposing COS-7 cells transfected with zebrafish PXR-TL, cod ARα and 
cod ERα to wastewater and sludge sample extracts from five different WWTPs in Bergen, Norway, 
several environmentally valuable discoveries were made. Multiple WW extracts significantly activated 
zebrafish PXR, and WWTP effluents did so to a larger extent than influents. Some extracts also activated 
cod ARα, whilst a majority of WW samples showed antagonistic properties towards cod ERα. No 
activation was detected in extracts from sludge samples. The use of LRA has uncovered differences in 
biological potencies in influents and effluents, as well as contributed with knowledge about differences 
between various WWTPs. 
By utilizing nuclear receptors from zebrafish and Atlantic cod, these findings also highlighted the 
possible adverse consequences that chronic release of wastewater might pose to aquatic wildlife. This 
is relevant information in an environmental management perspective.  
Direct correlation to compounds identified by chemical analysis was not obvious but the different 
approaches contributed to accentuate separate aspects and properties of wastewater-carried compounds, 
including detecting significant cytotoxic properties of extracts where the targeted chemical analysis was 
unable to do so. Furthermore, differences in compound and toxicity removal and activation were found 
for the individual treatment plants, although more research is needed to establish the significance of 
treatment method specifically. The singular sampling date, the targeted chemical analysis, and the three 
receptors chosen, do however only provide a narrow time specific, receptor specific, and compound 
specific image of the possible biological effects of substances present in the wastewaters released.  
 
5.6 Suggestions for future work 
The targeted chemical analysis aimed for specific compounds, meaning that a multitude of unidentified 
compounds are probably present in the extracts. A non-targeted analysis would provide a more complete 
picture of the compounds released as a wide variety of unknown compounds could be detected (Sobus 
et al., 2018). Furthermore, an effect directed analysis (EDA) where biological analysis, fractionation of 
extracts, and chemical analysis are combined, could be utilized to identify the key compounds 
responsible for the biological effects (Brack, 2003; Hong, Giesy, Lee, Lee, & Khim, 2016; Samolloff et 
al., 1983; Schuetzle & Lewtas, 1986). 
This thesis focused on a set of three different nuclear receptors from zebrafish and Atlantic cod, although 
multiple other receptors, such as Ahr (Aranguren-Abadía et al., 2020; Tanguay, Abnet, Heideman, & 
Peterson, 1999) and PPARs (Marta Eide et al., 2018; Ibabe, Grabenbauer, Baumgart, Fahimi, & 
Cajaraville, 2002) are present in both species. As a large amount of pharmaceuticals also target G 
protein-coupled receptors (GPCRs), and mixtures of pharmaceuticals in wastewater have been found to 
behave additively in GPCR assays  (Zhang, Ihara, Nakada, Tanaka, & Ihara, 2020), research on these 
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Table 1. Known AR agonists (non-exhaustive) 
Compound name Species* Reference 
Testosterone Human, zebrafish (Øye, Ivar, Borén, 2018)(Jørgensen, Andersen, 
Bjerregaard, & Rasmussen, 2007) 
Dihydrotestosterone (DHT) Human (Øye, Ivar, Borén, 2018)(Jørgensen et al., 2007) 
Nandrolone Human (Legemiddelhåndboken, 2015c) 
Chlormadinone acetate  Human (Siegenthaler, Bain, Riva, & Fent, 2017) 
TBECH Zebrafish (Pradhan et al., 2013) 
Trenbolone Human (Y. Park et al., 2021) 
Dexamethasone Human (Y. Park et al., 2021) 
Nandrolone Human (Y. Park et al., 2021) 
Androstenedione Zebrafish (Jørgensen et al., 2007) 
11 – Ketotestosterone Atlantic salmon, 
rainbow trout, 
zebrafish 
(Imamichi et al., 2016)(de Waal, 2008)(Hossain, 
Larsson, Scherbak, Olsson, & Orban, 2008) 
* this list does not consider the differences in binding affinity to AR between species. 
 
 
Table 2 Known AR antagonists (non-exhaustive) 
Compound name Species* Reference 
Cyproterone Human (Legemiddelhåndboken, 2016) 
Bicalutamide Human (Legemiddelhåndboken, 2016) 
Flutamide Human, zebrafish (Legemiddelhåndboken, 2016)(Martinović-
Weigelt et al., 2011) 
Bisphenol A Fathead minnows, 
human 
(Ekman et al., 2012)(C. Park et al., 2020) 
Bisphenol S Human (C. Park et al., 2020) 
Bisphenol F Human (C. Park et al., 2020) 
Benzophenenone-3 Zebrafish (Schreurs et al., 2005) 
3-benzolidene champor Zebrafish (Schreurs et al., 2005) 
Homosalate Zebrafish (Schreurs et al., 2005) 
Triclosan Human (Ahn et al., 2008) 
Octocrylene Human (Kunz & Fent, 2006b) 
Ketoprofen Human (Ezechiáš et al., 2016) 
Diclofenac  
ibuprofen  














Table 3. Known estrogen receptor agonists (non-exhaustive) 
Compound name Species* Reference 
Benzophenone-3 Zebrafish (Schreurs et al., 2005) 
3-benzolidene champor Zebrafish (Schreurs et al., 2005) 
Homosalate Zebrafish (Schreurs et al., 2005) 
E2 Zebrafish (Menuet et al., 2002) 
EE2 Zebrafish, Human (Notch & Mayer, 2011) (Miksicek, 1994) 
Bisphenol A Human, zebrafish (C. Park et al., 2020)(Serra et al., 2019) 
Bisphenol S Human (C. Park et al., 2020) 
Bisphenol F Human (C. Park et al., 2020) 
   
Et-PABA Human, Rainbow trout (Kunz & Fent, 2006a) 
* this list does not consider the differences in binding affinity to ER between species. 
 
Table 4. Known ER antagonists (non-exhaustive) 
Compound name Species* Reference 
AHTN Zebrafish (Schreurs et al., 2005) 
HHCB Zebrafish (Schreurs et al., 2005) 
Triclosan Human (Ahn et al., 2008) 
Tamoxifen Human (Legemiddelhåndboken, 2015a) 
Klomifen Human (Legemiddelhåndboken, 2015a) 
Fulvestrant Human (Legemiddelhåndboken, 2015a) 
Tamoxifen Human (Miksicek, 1994) 
Octocrylene Human, zebrafish (Kunz & Fent, 2006a) (Meng, Yeung, & Chan, 
2021) 
Diclofenac Human (Ezechiáš et al., 2016) 
Ibuprofen Human 
* this list does not consider the differences in binding affinity to ER between species. 
 
Table 5. Glucocorticoid receptor ligands (non-exhaustive) 
Compound name Species* Reference 
Cortisone Human (Legemiddelhåndboken, 2015b)(Chen, Jia, Snyder, 
Gong, & Lam, 2016)  
Hydrocortisone Human (Legemiddelhåndboken, 2015b) 
Prednisolone Human, zebrafish, 
mice 
(Legemiddelhåndboken, 2015b), (Chen et al., 2016) , 
(So et al., 2009). 
Dexamethasone Human, zebrafish (Legemiddelhåndboken, 2015b) (Chen et al., 2016)  
Triamcinolone Zebrafish (Chen et al., 2016) 
TMPP** Human (Q. Zhang et al., 2017) 
TPHP** Human 
TDBPP** Human 









Table 6. Known ligands for PXR (non-exhaustive) 
Compound name Species* Reference 
4BAB Human, zebrafish Lille-Langøy et al. 2019 
Bisphenol A Human Takeshita et al. 2001 
Cafestrol Mouse Ricketts et al. 2007 
Carbemazepine Human, polar bear Lille-Langøy et al. 2015 
Clotrimazole Zebrafish, human, polar 
bear 
Bainy et al. 2013, Lille-Langøy et. al. 
2015 
DEHP Human, mouse Takeshita et al. 2001 
Dexamethasone Human Pacussi, Drocourt, Maurel,Vilarem, 2000 
Diclofenac Mugilogobius abei Ku et al. 2018 
Ketoconazole** Human Lille-Langøy et. al. 2015, Takeshita et. al., 
2001 
Nonylphenol Mouse Takeshita et al. 2001 
Omeprazole Human, polar bear Lille-Langøy et. al. 2015 
Pregnenolone 16α-
carbonitril 
Zebrafish Bainy et al. 2013 
Rifampicin Human, polar bear Lille-Langøy et. al. 2015, Takeshita et al. 
2001 
SR12813 Human, polar bear Lille-Langøy et. al. 2015 
TCPP Human Kojima et al., 2013 
* this list does not consider the differences in binding affinity to PXR between species. 





































































































ng/ 500mL ng/ 500mL ng/ 
500mL 






Holen-in 6802.24 104.40 16435.50 0.00 18.78 154.32 106.94 8.42 
Holen-out 148.90 0.00 13426.43 0.00 35.84 154.30 407.58 12.48 
Kvernevik-
in 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Kvernevik-
out 
27.42 0.00 195.05 9.04 98.67 281.52 908.54 22.57 
Knappen-
in 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Knappen-
out 








230.42 69.38 11900.04 0.00 25.82 123.42 539.98 10.11 
 
LOD 75.02 50.08 28.31 74.78 83.49 68.23 76.09 101.93 
LOQ 227.34 151.77 85.78 226.62 252.99 206.77 230.58 308.88 
Blank 5.11 0.00 0.01 0.00 0.00 4.99 249.24 9.47 
 
 







ACE 0.641 0.526 
 
-17.9 
MET 2.347 1.682 
 
-28.3 
CAF 9.063 9.054 
 
-0.1 
PDS 0.248 0.202 
 
-18.5 
CBZ 0.099 0.086 
 
-13.1 
5-h DCF 0.360 0.187 
 
-48.1 
TCPP 0.358 0.347 
 
-3.1 


































































blank1 0.00 0.00 0.00 0.00 0.00 10.33 806.40 22.52 
blank2 0.00 0.00 0.00 1.23 0.00 7.91 280.50 10.80 
blank3 0.00 0.00 0.00 0.00 0.00 13.42 2365.81 59.49          
Average 0.00 0.00 0.00 0.41 0.00 10.55 1150.90 30.94 
Sd 0.00 0.00 0.00 0.58 0.00 2.25 885.49 20.75 
Sd % 
   
141.4 
 
21.4 76.9 67.1 
 
